a) High Risk Investment: As the name suggests, high risk investments are full of risks. While they promise high returns, they may also cause huge losses. There is little to predict because of the volatile nature and requires the investor to be on his feet at all times and there is virtually no way to categorize a particular stock into high return or low return brackets. However, before investing, you should know that in order to prosper, it is important to keep a cool head and not panic.
b) Moderate Risk Investment: This form of investment acts as a balance between high risk and low risk investment. While there is lower volatility compared to high risk, it is definitely higher than low risk. On the other hand, the returns on investment are higher compared to low risk but lower compared to high risk. In short, this type of investment is for those who want good profits but at the same time are not ready to take high risks.
c) Low Risk Investment: These are investments which are very stable and carry minimal risks. As a result, they are more predictable which allows the investor to breathe easy at all times. However, the returns on investment are not high but very low compared to the others.
For someone who can afford to spend a major part of the day looking at the figures, the best place to invest would be high risk wherein even if something goes wrong, immediate rectification measures can be taken. On the other hand, for those who are just looking for a place to invest, low risk investment is the place to be. Make sure to do some research before placing the money in the market. It is nothing but small factors that decide whether the investor makes profits or suffers from losses. To be a part of the former, one has to be smart and accurate.
A ~43MIL OS gives this stock an ability to be accumulated quickly, and LUVE is flirting with its 2 Major SMA's right now. A break and hold, golden cross, +Macd Cross, and nearly Bullish RSI have Technical Analysts frothing at the mouth.
Just recently, LUVE has changed its Business Strategy and Name to LUVE Sports. The CEO summarizes the need and reward to change nicely,
We have a number of options presenting themselves to us in terms of wider variety of products. We believe the best path to profitability is to broaden our product base. By doing this we access larger numbers of consumers and ultimately improve our ability to generate greater revenues. Our distribution channels are in place, it makes good business sense for us to increase what we are able to deliver to our clients.”
Over the last few months, the company has delved into some Ambitious business moves to attack their industry hard and increase sales and profitability as they grow their brand name. LUVE has launched a new website while in the process of a name change. To amplify business, LUVE is developing relationships with Big Box retailers, increasing Sales Staff, pursuing a large distributor, and cleaning up their financials and releasing audits. Let's look closely at the progress LUVE has accomplished in swift fashion.
LUVE Sports is a sports distribution company focused on delivering industry-leading sport products to the Mexican markets with the plan to expand into the South American markets. To date, the Company has introduced products to the market and established key relationships with corporate partners with proven distribution networks. For more information visit our corporate website at: http://www.luvesports.com/.
Since 2008, Linea Deportiva Prince Mexico (Prince Mexico S.A.) has had the exclusive rights to sell Prince, Ektelon and Viking brand name products in all of Mexico with the ability to expand into areas of South America. Authentic Brands Group, the international company that owns Prince Sports Group, has been around since the 1970s and has five sports it produces products for: tennis, squash, racquetball (Ektelon), paddle ball (Viking) and golf.
Their growth over the past few years has been impressive, but they are confident that growth in the coming years will be much stronger. LUVE has recently developed relationships with the top retailers in Mexico and look forward to purchasing the inventory needed to supply these large customers.
To fully understand their current product breadth read through the Products Page.
Accountants should have all the required information needed to complete the audit to De Joya Griffith.
Once the audit had passed through partner review they will be filed and the yield sign will be removed within one day of filing the financials.
Luve has been vocal in their attempts to rapidly an aggressively grow business. Releases on Large Partnerships, Sales Staff, and Distributors have brought much attention to this Growth phase sporting retail investment. Traders are Pumped to see the benefits of these new plans.
LUVE has them as a client and are looking forward to increasing inventory in their Mexican warehouse to take advantage of this distribution opportunity.
LUVE Sports has had a relationship with Walmart Mexico since 2009 and is looking forward to continuing to sell more products to them in the future. The revenue growth potential just within Walmart stores in Mexico presents an exciting opportunity for LUVE Sports.
They have been a huge success in Mexico being the largest private sector employer in the country with over 200,000 employed at over 2,030 locations. They are the largest retailer in all of Latin America and one of every 6 Walmart locations in the world is located in Mexico.
LUVE is planning to pursue a strategy of growth that includes an emphasis on product placement in "big box" retailers such as El Puerto de Liverpool S.A.B. de C.V.
They have had a successful retail relationship with Liverpool stores since 2009. Liverpool was founded in 1847, operates 85 mid-to-high end retail stores within Mexico, and had over $4 billion in revenue last year.
TALK ABOUT SOME BIGTIME NAMES!!!
What does the Sporting Retail Industry look like in Mexico?
Mexico is the largest targeted market for imported sporting goods in Latin America, accounting for over 60% of the revenue or $266 million of the $437 million industry in 2012. Over the past five years, LUVE Sports has built solid relationships with clients such as Walmart Mexico, Sears Mexico, Liverpool and Marti to name a few. Combined, all these companies have over 2,000 locations just within Mexico.
LUVE is positioning itself to GROW in a BOOMING Mexican Retail Market. They are crossing their needs off the list and gaining Value Credentials in doing so. Fundamentally, LUVE is putting itself in a position to prosper, and at these prices we think now is THE TIME to look long and hard at this STELLAR DAILY CHART.
LUVE is looking to pop from $.13, and the timing seems to be better than ever.
LUVE is nearing a BREAK of the 20 and 50 SMA's!!! A break and hold of theses SMA's at $.13 could point to a Breakout with NO Resistance in sight.
RSI is Right Near 50. A breach would set off another Bullish TA Catalyst.
The last +MACD Cross sent LUVE from $.15 to ~$.24. LUVE would love to get back to the $.15+ Channel and make Another Run to $.24 or higher given the same TA Catalysts and EVEN Better News accompany it!!!!!!
Briefly before that, LUVE ROCKETED to $.44 on the heels of changing business directions a bit and augmenting the growth plans!
A Return to $.15, $.24, and $.44 could spell potential profits of 15%, 85%, and 238% respectively.
Look at the future this company has ahead of itself and the Sales Growth that should be well on its way when they are transparent with financials and more liquid. You have to Buy Before the Stock deserves its higher valuation more often than not, and LUVE is showcasing quite the opportunity right now.
We hope you enjoy our LUVE Trade. Continue to do your DD, and Trade Wisely!!!
Disclaimer: Stockchat LLC has received three thousand five hundred dlrs for the awareness of LUVE by a non-controlling third party MajorPennyStocks. Stockchat LLC has previously received three thousand dlrs for the awareness of LUVE by a non-controlling third party that has expired.
BLDW has been steadily rising since May. The stock has patiently soared to $.04-$.055, and it is breaking all the SMA's in sight.
With a ~10MIL Float, BLDW may see quick moves north if accumulation continues taking this stock higher - a Vertical move may be in the BLDW future!
News flow has really picked up of late causing the daily volume to surge since August. The company has recently seen progress via LED Retrofits and new projects needing Solar Garages and LEF Retrofits.
Their entrance into this business is rather new, and they are flourishing already. Let's looks closer at they progress BLDW has made.
The Project included replacing all existing lighting in their 90,000 sq-ft warehouse, manufacturing facility, executive offices and all other interior and exterior lighting, with cost saving LED Lighting..
The clients was very satisfied with the work done. Client CEO stated "Our facility is much cooler now, and being in Texas, we will realize a huge savings on our air-conditioning; but probably the most noticeable difference to the staff, is the quality and richness of the new LED lighting. It's like being in a whole new facility, and has had a dramatically positive effect on not only the work environment, but the attitude, and well- being of our staff. I plan to do additional projects with Building Turbines, and the only thing that I regret about this one, is that we did not do it sooner."
BLDW's CEO had this to say about their newfound relationship.
Completing The FreshBrew Group installation is yet another milestone achieved by BLDW. This project brings tens of thousands of dollars of revenue into the company, allowing us to continue to implement our strategy of becoming a one stop shop for all urban Green Energy Solutions. The project went so smoothly, and the results were so dramatic, that Mr Ansari is already having us look at additional projects, that we look forward to signing in the very near future."
Through Green City Planet they have not only introduced a new Solar product line but have been awarded their first nearly $1M lease project, financed through Nsite Investment Group LTD.
The Project includes a complete LED lighting retrofit for a 55,000 sq-ft office building in Austin, TX as well as the installation of a new Solar Parking Garage. A second 55,000 sq-ft building will follow shortly after based on installation results and savings.
Based in Austin, Texas, Building Turbines, Inc. is focused on the design and manufacture of patented rooftop wind turbines; as well as, vertically integrating into other renewable energy solutions to complete a total Green Energy Solution for any urban environment. Visit their website at www.buildingturbines.com for more information
Why is Wind Technology in such favor right now?
The BTI turbine technology takes advantage of the natural force of wind as it interacts with a building. When the wind accelerates up the side of a building and reaches the edge of the rooftop it creates a vortex that perfectly aligns with the BT turbines’ horizontal axis for maximum efficiency. Its’ innovative and patented design leads to an affordable solution that has many competitive advantages and is effective at creating clean, renewable on-site power.
Wind is a premier renewable energy source with zero emissions
Wind energy can help alleviate a stressed and antiquated grid system
Wind energy can also help reduce over-all dependence on fossil fuels and foreign oil
Allows customer to realize corporate responsibility to environment and save bottom-line dollars
Generate electricity even at moderately low (8+ Mph) wind speeds
Federal, state, and city rebates currently exist to reduce capital costs
Produces power on-site (where it is needed) – avoids costly transmission and associated power loss – helps reduce demand on stressed grid system (and offset coal-related emissions)
Creates power 24/ 7 with sufficient minimal wind speeds (night or day, sun or clouds)
Multiple electrical configuration possibilities exist to maximize flexibility
No storage via batteries (generate and consume directly in building)
Storage via batteries with ‘smart meter’ technology to directly offset peak usage times and achieve maximum savings
Wind energy can improve the energy impact of any building it can be mounted on
Wind energy is complimentary to solar thus creating potential cost optimizing synergy (shared ‘system’)
What is the new Green City Planet that BLDW has created?
In July of 2013 Building Turbines, Inc. announced the formation of a new subsidiary, Green City Planet.
As stated in the related press release by John Graham, CEO, Building Turbines:
"The formation of Green City Planet, and other planned divisions, are an excellent example of implementing our vision of vertically, and/or horizontally integrating all technologies and
aspects of renewable energy into a one stop shop for a total Green Energy Solution, for any urban environment."
BLDW is flirting with 52-week Highs right now. If we look at the DAILY and WEEKLY Charts then you will see we have Broken Major SMA's and are flirting with even more breaks.
The 50 and 200 SMA's have been broken and held on the Daily.
52 Week Highs and a 200SMA Break on the Weekly are near!
A run back to and above Ten Cents may be in the cards as news continues.
BLDW is a GREAT Green Technology trade that has just recently closed some relatively big deals. We believe this stock may have a great future ahead, and we hope you enjoy BLDW.
Continue to do your Due Diligence, and trade wisely.
Disclaimer: Stockchat LLC has received two thousand five hundred dlrs for the awareness of BLDW by a non-controlling third party One22Media LLC.Stockchat LLC has previously received twenty seven thousand five hundred dlrs for the awareness of BLDW by a non-controlling third party which has expired.
Since, LVGI has developed their Management Team, Product Line, Advertising, Websites, and Popular Icons. The future is a dazzling glint coming into view! Let's look more closely at these recent endeavors that have traders in a hullabaloo!
LVGI traded over $80,000 today after the company inked a Major Advertising Deal. They are checking growth-mandates off the list at a reassuring pace, and investors are loading up while the Market Capitalization remains at ~$2.7MIL.
Located in Holbrook, New York Limitless Venture Group Inc is a full service brand development company specializing in beverage, supplement and healthy lifestyle products. Limitless Venture Group Inc has internationally recognized formulators, in house graphics department, in house web design team, and full support staff for marketing and distribution chain development. Limitless Venture Group Inc. proprietary product line consists of SLAM Infusination™ Limitless Body™, Limitless Health™, and G.E.A.R™. Visit www.lvginc.com to learn more about the Brands, Services, Team, Marketing, Manufacturing, and more!
G.E.A.R.™ is an all inclusive Nutraceuticals line not specific to any particular sport. It is ideal not only for professional athletes at the highest levels but for any individual looking to get into shape and live a healthy, active lifestyle.
The Muscular Development Magazine is to Feature G.E.A.R. in Comprehensive Print, Online, and in Sponsorship Campaigns. G.E.A.R. Prints Already Appear in the September and October Issues of Muscular Development Magazine (http://www.musculardevelopment.com).
The one-year deal consists of online, print, and radio advertising plus GEAR-TV, which will be on the G.E.A.R. website, as well as a dedicated channel on their site.
With a paid circulation of nearly 300 thousand and more than one million readers per month, Muscular Development Magazine is the premier advertising venue for the soon to be released G.E.A.R. product line.
LVGI has a Dedicated GEAR-TV Channel on www.musculardevelopment.com which gets more than 2 million page views a month!!!! How is that for recognition! This is how you BRAND and Grow Sales!
Why has LVGI chosen MD as their advertising modus operandi?
Scalise has stated,
We are committed to creating a multi-channel marketing program that reaches not just those in the health and fitness arena but to anyone who is interested in developing a healthier lifestyle. MD is by far the number one media platform to reach the bodybuilding and fitness community worldwide and I consider MD CEO and Founder Steve Blechman to be the new Joe Weider of bodybuilding. To that end, we will be aggressively pursuing creative opportunities to reach a broad spectrum of markets."
PEOPLE are what Turn Small-Cap Growth Companies into Incredible Investments. People are the Most Important Variable, and LVGI is taking care of business. LVGI has made Major Hiring Announcements as they bring Professional Talent and Top Names to different business Divisions: Director of Product Development, VP of Athletic Marketing, and a SR. Executive Management Team for the G.E.A.R. Sports Nutraceuticals subsidiary comprising of a President, COO, and CMO.
An ALL-STAR TEAM has been created and will continue to be cultured! LVGI intends on taking the multi-billion dollar supplement market by storm.
LVGI plans on making a very proactive and creative push to ensure the G.E.A.R brand sets new standards in innovation unlike the industry has ever seen. The focus of product success will be health benefits the user can feel, and an actionable point of difference that no one other company can duplicate.
In 2012, products developed by Pete Maletto have amassed over 1.2 billion in gross sales for his clients, with 80% of those sales in the sports nutrition arena.
Shawn Ray will officially join the G.E.A.R. team as of August 15 in preparation for the launch at the Mr. Olympia contest September 26-29 in Las Vegas.
Shawn Ray's affiliations will be one of the key components in helping streamline the family of G.E.A.R. products both in the U.S. and abroad. Read the Release to fully understand JUST HOW Diverse his relationships are and how far reaching his services will be!
Levrone, affectionately known as the "Maryland Muscle Machine," earned 22 professional IFBB wins including the Arnold Classic twice and four times came in second in the granddaddy of all IFBB contests Joe Weider's Mr. Olympia.
The Industry Star-Studded Hiring Technique may increase shareholder value. LVGI is following the highly successful approach taken by OTC counterpart MusclePharm.
G.E.A.R™ sports nutraceuticals subsidiary logo was prominently displayed before the nationally televised event.
This is the ideal event to showcase G.E.A.R. in a main event on Fox's new network. The event marked the debut of Fox's new Fox Sports 1 Network.
The Company also recently announced it has signed on as a major sponsor of "Joe Weider's Olympia Fitness and Performance Expo" September 27-28 at the Las Vegas Convention Center.
SHOGUN will be at the Company's booth to meet fans, sign autographs, etc. The event is considered the ultimate body building and fitness extravaganza with anticipated attendance of more than 50 thousand.
G Shock™, which is the company's flagship pre-workout product, will be, accompanied by E Shock™, the all day energy/endurance enhancer and Maxx Shock™ post workout supplement which focuses on muscle recovery.
LVGI transparently laid out the Product Qualities, Divisions, and Estimated Future Endeavors in their Shareholder Update (June 21st) after the restructuring. Limitless Venture Group, Inc. (LVGI) is a development stage company dedicated to the production, distribution and marketing of unique, quality product lines. LVGI is a full service brand development company with an in-house bio-chemical engineering and formulations department; in-house brand identity team, full graphics department as well as an experienced and highly motivated group of marketing professionals. Several Product Lines are readying to Go-To-Market! Events and Branding opportunities are being sought and capitalized upon.
Now is the time to look long and hard at the Daily Chart before event-driven movements may leave you in a "wish-I-would-have" moment. At $.021, LVGI is at an ALL-TIME LOW, and 007 sees that a Huge Opportunity!
RSI is now at ~26 after an active day consisting of ~3.3MIL Shares Traded (~$80,000).
The last several instances in which RSI broke below 30 were followed with positive rebounds by LGVI - History may repeat itself. We LOVE our Bottom-Bouncers and Oversold Opportunities within Strong Corporations.
The 20 and 50 SMA's offer logical targets at $.059 and $.094 for prospective gains of 180%-347%!!!!!
LVGI has been in search of its footing and trading channel as traders seek an appropriate valuation following the restructuring.
A Float of ~22.6MIL, Market Cap of $2.7MIL, and Past and Planned Developments have many traders thinking a return to $.10+ is in the cards!!! That is why we are here doing our research. We love this trade!
LVGI is making all of the necessary moves to create a flourishing player in a Billion-Dollar Growth Market! They are eating up the big names across different Fitness, Athletic, and Well-Being Markets, and they pride themselves on QUALITY PRODUCTS that generate buzz.
Look at the competition merely wanting BUZZ to surround a dime-a-dozen drink with a no-name icon to be the face. LVGI is the cream rising to the top.
Continue to do your research on the Products and People involved before they all hit the markets.
We wouldn't want you to miss out on any gains. Trade wisely, and give us your feedback!
Disclaimer: StockchatLLC has received three thousand five hundred dlrs for awareness of LVGI by a non-controlling third party Outreach Holdings S.A
The GLBH Chart is fresh off an oversold RSI bounce and flirting with a break of the 20SMA at $.01. This sub-penny trade has fallen from $.10 since June, and liquidity has maintained a strong presence.
Traders were delighted with a Late-May PR detailing GLBH's entrance into the Property Casualty/Life and Health insurance arenas. Since then, the company has been on a tear releasing one corporate development after the other.
At such a cheap price, GLBH now poses a strong risk/reward scenario given the current progress and expectations the company has laid before traders.
GLBH has detailed an ambitious acquisition strategy, identified and approved deals, expanded operations, and more.GLBH is attacking densely populated Southeastern markets, and Management has given Guidance for Strong Revenue Growth in the Second Half of 2013!!!!
With such strong recurring revenue projections, NOW would seem to be the PERFECT TIME to devour some dirt-cheap shares before the numbers are in. Let's look at what has created such bullish outlooks!
Global Agency Holdings, Inc. (GLBH) is a progressive insurance brokerage firm that provides turnkey solutions to protect their clients' financial interests. The Company's comprehensive approach includes personal and business insurance programs from personal auto, home, health, life, as well as commercial auto, general liability, workers compensation and group/life to meet all of their clients' insurance needs.
Global Agency Holdings, Inc. remains focused on continued expansion through acquisitions of insurance agencies in the Southeast section of the United States. For more information on Global Agency Holdings, Inc., please visit http://glbholdings.com/.
The name change is in line with the company's mission to expand and acquire existing highly profitable P&C and Life and Health agencies. The name change is being filed with FINRA and is anticipated to become effective in September.
The company is expanding its corporate offices in Thomasville, GA to accommodate growth.
The Board of Directors has approved the expansion of the corporate offices. The Company is in the process of securing a new lease that will accommodate Corporate needs but also provide office space for one of its health and life insurance agencies.
GLBH and its management team are showcasing a valuable ability to be flexible and change when industry winds have shifted. GLBH Chairman and CEO, Ormand Hunter stated,
Recent changes in the ACA have caused the company to take pause and evaluate its primary direction. We feel that the Affordable Care Act will prove to be a profitable venture for our company. It is our intention to continue to monitor the ACA and move into that market when the time is right." Mr. Hunter further stated, "Unfortunately, with the recent announcements coming out of Washington, we must adapt to government actions and capture market share in current high margin insurance sectors such as traditional life and health."
With an estimated 65 million Americans being un-insured related to health care¸ GLBH sees this opportunity as a huge potential revenue generation stream for the company. The CEO stated, "We have extended our marketing and acquisition plan to insure GLBH is positioned to take full advantage of the potential revenue created by this legislation thereby increasing shareholder value."
With the new market created by the Affordable Care Act, GLBH will focus its acquisition strategy and creation of new agency offices in the highly profitable Life and Health care insurance markets.
According to experts, the effects of this legislation upon the stock market are likely to be positive. Insurance companies are likely to continue the positive appreciation of their stock. There will be tens of millions more insurance customers paying into the system and the insurance providers will be allowed to raise premiums across the board to cover enrollees that were previously un-insurable.
Just How Aggressive is the planned GLBH Roll-Up Strategy?
GLBH is targeting 5 Key Acquisitions. The acquisition candidates have combined annual revenue of $750,000. All revenue is typically recurring with steady year over year increases. The insurance agencies are located in the densely populated Florida markets of Jacksonville, Ft. Lauderdale and Miami.
In addition to acquiring high growth insurance agencies, Globaltech is seeking to purchase technologies that will streamline their growing operations.
What Business Growth Strategy does GLBH adhere to? What is their Acquisition Criteria and Approach?
The GLBH focus is in the highly profitable Property Casualty/Life and Health insurance industry. Most insurance agencies are small entrepreneurs who employ less than 10 people. While their business provides a stable living for them, many of them struggle to grow because of under capitalization.
Under capitalization is the number one reason most businesses fail. Many small business owners would love to expand their businesses but either do not have the borrowing capacity or the business knowledge to grow their small, privately managed entity.
GLBH acquires small insurance agencies and funds their expansion thru stock offerings in addition to providing world class financial and managerial over site to insure a successful, planned growth of the acquired company. The management team analyzes all aspects of potential acquisition companies and makes acquisitions of well managed, highly profitable companies who meet our investment criteria.
In this way, management teams for each of the target companies remain intact and are thereby empowered to expand debt free. If funds for expansion are required, these funds can be provided thru shareholder investment or other means without company management being personally at risk.
The current target clientele are as follows: business owners of all kinds including but not limited to, convenience store chains, hospitals, medical complexes, professional office complexes, apartment complexes and condo complexes in addition to home owners and small business owners. These target markets consist of states such as Florida, Georgia and Alabama with an eye on the states bordering the Gulf of Mexico including Texas and eventually, California. The target states mentioned in addition to South Carolina and others, total 8 states. According to the 2012 census, these states comprise 110 million people or about 1/3rd of the entire U.S. population.
Is GLBH in a great industry with opportunities present?
Business and personal insurance is a necessity of life. In many cases it is mandated by law as in the case of mortgages or auto loans. This mandate is to insure the banks and property owners against loss. The property/casualty, life and health insurance industry generates billions of dollars in revenues annually. Florida and Georgia will remain Globaltechs initial focus to build residual revenue growth in 2013. Globaltech's management lives and works in these densely populated markets. This allows the company to focus on increasing existing market relationships with acquisition targets and end clientele.
GLBH is in an Industry where they can leverage their resources to successfully group together (acquire) and choreograph a dance of small but profitable similar companies. The Chart has basically bottomed out, and the company has declared that the next few months will show Sales Increases from acquisitions. One may consider the price to be ripe for the picking before a surge on spectacular news. If we Look at the Daily Chart, you will notice several swell marks.
RSI has bounced off 30 - Oversold.
At $.008, GLBH is cuddling up to the 20SMA at $.01 for a potential break up to the 50SMA at $.03 - Closing the GAP near ~$.018 won't hurt either!
100%-200% runs may come quick here on any given volume and a TA jolt, but a rise to the $.04-$.10 channel would really give traders what they came for. That may require GLBH to follow up on recent actions over the next few months, but Patience may Pay.
GLBH is just so cheap down here, and has so much going in a brief time that we feel it could be overdue for a big rebound. We hope you enjoyed this equity and encourage you to keep doing your research and trading wisely.
Disclaimer: Stockchat LLC has received twenty two thousand dlrs for the awarness of GLBH by a non-controlling third party Lattria Group LTD.
The increased action all started in Late-May when TENP related their entrance into the USA Weight Loss Market - all ~$66BIL of it!Since their acquisition of an Exclusive USA License to Proteina21, TENP has gone on a rampage adding the Canadian and European Markets to their growth hitlist. Sales and Marketing Agreements are now in place as is a New Website and New CEO.
Technologies-Scan Corp is database management company specializing in the development of several internet base software applications for the health and consumer wellbeing markets. The company signed an exclusive USA marketing and distribution license for the Proteina21 weightloss products line.
Last Week, TENP set the stage with a Monster PR indicating that Sales are on the way. This is a HUGE Moment in a growth-stock's cycle, and it is causing quite a stir in the trading.
November 1st is the slated date for entering the $66BIL USA weight loss market.
What does the Proteina21 Product Line look like?
Proteina21 is a product line of food supplements and ready-made meals high in protein and low in carbohydrates designed to help people lose weight. The Proteina21 product line will consist of several different weight loss products. Convenience is key here creating separation from the competition. The products are shipped overnight and are available thru internet sales on their website http://www.proteina21.com
Having a Professional, Enticing, Transparent, and fluid Website is mandatory in a situation where sales are routed through a corporate website. TENP has made the right moves in hiring Sales and Marketing Teams to promote and develop the New Website. The New CEO has found it paramount in becoming a successful company.
Its current website www.techno-scan.com reflects the new sales and distribution agreement with Proteina21 weight loss product line.
CEO Patrick Aubé stated
The new website is designed to better reflect what we are doing with Proteina21. Having myself a strong background in internet sales and technology, updating the website was a priority for me when we signed the license agreement for the weight loss product line. It is the corner stone of our business model and thus special attention must be put on this aspect of the business"
This move was part of the plan when we signed the license agreement," says Ghislaine St-Hilaire, the now former CEO. "Patrick Aubé is a serial entrepreneur with over 18 years experience in computer technologies and Internet sales, his expertise will greatly benefit the company and shareholders, Patrick is a recognized Internet marketing expert and author of a bestselling book sold in 40 countries on all you need to know to generate income on the Internet and was nominated as Entrepreneur of the Year in the prestigious Ernst & Young 2010 contest."
Aubé created Social Media Geek Inc and operates the popular website www.chezmaya.com, one of the largest French-speaking websites in the world, with over one million unique visitors every month. Social Media Geek also specializes in database technology and media social networks.
Due diligence was thorough and quick on the letter of intent TENP signed earlier last week, both parties worked extremely hard on getting it done quickly so to start sales as soon as possible. The company is thrilled at the prospect of getting to work on sales of this great product line in the US. The US boasts a $66BIL weight loss market, and TENP wants a part of it.
TENP saw a bigger synergy for respective companies than just the US market and that is why they entered discussions concerning the Canadian market. There, Proteina21 has had sales of over $500,000 in the first quarter!!
TENP had developed a growing and great relationship with Social Geek Media. They are desiring a bigger and better fit for their companies than just the US and Canadian markets. TENP quickly turned their attention to a Vast European Market.
TENP seems to have it all in place. Their plan of operation is selling and distributing health products, including a health database system. TENP developed an exhaustive database and software for natural health products. They believe their Medicus21 software is a unique information provider of natural health products to be used through a mobile application and barcode reader. It enables the user to scan any natural health product’s bar code, through the help of their smart phone, and instantly obtain all nutritional information, use, benefits and a plethora of information on the product.
Their Joint Venture with SGM includes the design, technologies, how to, development, production and sale of nutritional, protein and dietary supplements online. All Proteina21 products have common features, including:
A flavor, taste and format tailored to market needs
Quick and easy preparation
Rigorous manufacturing standards.
For more information on Proteina21 please visit the Home Site HERE. From Shopping, Coaching, Dieting, Promotions, and Challenges, it can all be found at the Proteina21 Home Page. The Partnerships they currently have and are developing are all Modern, Essential pieces to the success story here. Here are a few:
Bottom bounce charts are all the rave lately and WBXU just hit the scanners and has the potential to be a nice play.
Lets take a look at the chart and see why I am bullish on WBXU:
1. RSI - Oversold at a value of 17. Last time the RSI dropped so low there was a uptrend of over 40%.
2. MACD - Trending under the zero line and has moved away from the signal line forming a bullish signal, solidifying the bottom bounce indication.
3. Acc/Dist - At absolute bottom and providing an open road of opportunity.
4. Price, this is big bounce indication as price fell bellow the bottom bollinger band on Thursdays trading day.
Chart traders hunt every night for a chart that the price is trending under the bottom bollinger band as when that happens there is a very high chance that the price will move back up to trade inside the bollinger bands.
Closing at .023 on Thursday trading day, the bottom bollinger band is currently at .03 which is 33% above the closing price.
Assuming that the price goes up to trade above the bottom bollinger band, 33% is a nice profit, but what will happen when that type of move hits scanners?
As you can see, WBXU can go parabolic, and tomorrow could be the start.
WBXU is a media company that owns and operates a network of consumer branded websites and businesses focused on Customer Acquisition, E-Commerce and Mobile Media. Webxu's mission
is to build the highest performing media network in the industry. Through its branded consumer websites and mobile advertising, Webxu generates revenue by providing advertiser clients with
targeted consumer traffic.
Start your research on WBXU right away as this could be an explosive opportunity.
Remember, trade smart, use stop losses and if you happen to see your self in profits, it could be
wise to take advantage of the situation.
Disclaimer: Stockchat LLC has received Three Thousand Five Hundred Dlrs for the awareness of WBXU from a non-controlling third ODD Marketing LLC
BRZG bottom bounce chart is unbelievable and could produce record breaking multi day results.
Click and look at the chart then follow along.
1. BRZG is known for producing multi day gains on small volume.
2. Support was established at .0012, then a small down shift has now established
a three day tested support at .0007.
3. RSI sitting at over sold territory, a very bullish indication.
4. MACD Histogram reached bottom peek three days ago and is moving back up toward the zero line, a very bullish indication.
5. MACD is trending FAR BELOW the zero line and is about to touch the indication line which would cause a bullish up trend.
6. Acc/Dist - This is why the first support at .0012 didn't hold as the accumulation was still half way on the graph, now at .0007 its at the absolute bottom and changing direction from down to flat, which is a very bullish indication.
As you can see BRZG could be called "the perfect bottom bounce" set up.
Now all you have to do is enjoy the ride.
Start your research on BRZG right away as this could be an explosive opportunity.
Remember, trade smart, use stop losses and if you happen to see your self in profits, it could be
wise to take advantage of the situation.
Spy Hard, Profit Easy
Stockchat LLC has not been compensated for the awareness of BRZG.
Bio-tech trades are One of only a FEW Niche Trading Universes where Multi-Bagger Returns come around often. They offer the Dream Trade where fortunes can be made in a moment's notice. PLPL has been on a TEAR since March-April, and we believe this is just the beginning phase of Value being Unlocked.
At ~$.61, PLPL has just hit New 2 Year Highs! Traders are Flooding in, and we think PLPL may now be gearing up for a run to the 200SMA at $.81 for a quick ~33% Profit!Per an early August Release, Investors will notice that a significant amount of research and development activity is slated to commence in the fourth quarter of 2013 - Major Milestones Ahead Should Drive Plandai Shares Higher.
Two important studies slated to start at the end of the year include the first study to test the absorption properties of the green-tea based Catechin Complex in human subjects. The objective of this investigation is to measure human bioavailability of Phytofare™ Catechin Complex.
This study will be followed by a trial to test the effects of Phytofare™ Catechin Complex in inducing weight loss while also improving cholesterol and lowering blood pressure.
Separately, independent scientific investigations of Phytofare™ Catechin Complex in both powder and nano-encapsulated forms will be undertaken in 4Q13 both in vivo and mouse models to validate the extract for oral and topical formulations as an antimalarial drug.
Meaningful production and distribution should commence in 4Q13 as well. Plandai expects commercial production to commence by the end of Q4 with a daily volume estimated at 290 kg of total formulated Phytofare™ catechin complex. The Company's nano-encapsulated product will be made available sometime in 1Q14. Also planned for Q4 is the distribution and marketing of Phytofare™ as noted in a previous Company press release.
Expect Trading Volume and Action to Pick Up Bigtime!!!! Valuation Speculation is Soaring on the Heels of Breakthrough Developments across several Medical Fields! WE have been witness to some astounding Trades that target and capitalize upon the surging Nutraceutical Industries, but PLPL is Stealing the Show!
Plandai has the opportunity to be crowned the Green Tea Extract and bioavailability leader. A Research Report notes that the likely favorable results of the PLPL trials should enable the Firm to successfully market its product to manufacturers for use in health prevention and wellness, beginning in late 2013.
PLPL Phytofare™ is suspected of being a Game Changer and Cash Cow in the lucrative and needed Weight-Loss (Child Obesity), Common Cold and Flu, Malaria, Colon Cancer Prevention, and Mental/Physical Well Being fields such as Anti-Aging and Increased Memory Functioning. These Markets are Vast and vulnerable to growth-stage innovators such as PLPL. We are here at the right place and right time!
Plandai Biotechnology, Inc. and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandai Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its patented Phytofare™ extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include food and beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.
Plandaí Biotechnology is the culmination of over ten years of research in the field of plant extracts. Its principle holdings consist of land, farms and infrastructure, totaling more than 8500 acres, in the province of Mpumalanga, South Africa.
PLPL has developed an Incredible Array or Products, a Branding and Marketing Program, Distribution Agreements across N. America and Europe, and Vertically Integrated Farming Operations in South Africa involving hundreds of experienced Employees who are thankful to see this Industry return to its roots!!! If you have not seen the News these past few months, then make sure your seat belt is buckled!!!!! PLPL is targeting $25MIL-$90MIL in Sales - It is easy to see why the Buzz and Trend is Growing.
Since our Last Alert, PLPL has showcased Just How Significant of a Player it IS in the fight against Colon Cancer, as a competitor against other Malaria Drugs, and as a Child Obesity combatant and Weight-Loss catalyst. Trial Results have investors blushing!
In 2013 nearly 240,000 men will be diagnosed with the disease and nearly 30,000 will die from it in the U.S. alone. Plus, one in six men will be diagnosed with prostate cancer at some point in their lives.
Plandaí Phytofare Carotenoid Complex is a unique product that harnesses the beneficial effects of these nutrients due to the Company's proprietary and advanced extraction process and ability to generate high absorption into the blood stream. In fact, the product will offer one of the highest levels of lycopene found in a dietary supplement. Looking at the Company's line of offerings, this will be the third product in the Plandai arsenal that will be marketed and sold in 2014.
Men who consume a significant amount of lycopene reduced the risk of developing the disease by 35%
Over 32% fewer people in the green tea group experienced no cold and flu symptoms compared to the placebo group, and nearly 23% experienced less symptoms lasting fewer days.
Users can reduce their consumption of extract and yet still receive tremendous health benefits from the Firm's products. Plandai's Phytofare™ nutriceutical product line is set to be launched in the fourth quarter of 2013. The product's superiority will no doubt benefit top-line revenue and earnings growth especially if used as cold and flu treatment and prevention.
The use of mefloquine hydrochloride, an antimalarial drug given routinely to soldiers in necessary parts of the world, has dangerous side effects just now coming to light per CBS News Reports. It is estimated that tens of millions are treated with it today.
The market needs a real alternative with a high degree of efficacy that does not carry a poor side effect profile. This alternative may ultimately arrive in the form of Plandai's Phytofare™ Catechin Complex. The Company recently announced incredible results from its second round of in vitro testing of Phytofare™ Catechin Complex, used to kill the malaria parasite plasmodium falciparum. The results of this independent investigation confirmed a twelve-times greater efficacy in killing the parasite.
The bioavailability study will not only test the absorption of Phytofare™ Catechin Complex, but it will compare Phytofare™ against a generic green tea extract and a branded product that touts higher bioavailability.
Plandaí has contracted with KGK to simultaneously perform a human weight loss trial to test the effects of Phytofare™ Catechin Complex in inducing weight loss while also improving cholesterol and lowering blood pressure.
The Goldman Report indicates the Trials could be Monster Catalysts for Widespread PLPL Product Use - The lack of bioavailability has halted broad use of these products for these applications. In their view, these huge milestone events raise the Company's profile and should substantially increase the Firm's valuation.
PLPL appears to have a leg up on the competition in a competitive product category worth hundreds of millions in annual sales.
The Plandai trial is likely to demonstrate significantly greater bioavailability than the typical 2-13% garnered by competing products, which should foster better-than-historical results. Moreover, the Phytofare™ Catechin Complex is comprised of more than just the EGCG catechin, which should pack an even greater punch through its absorption and weight loss effect.
The tea estate rehabilitation has involved extensive infrastructure deployment in addition to pruning and weeding of the tea plants. We needed to rebuild many of the roads and bridges and then refurbish the housing and other production buildings on site. As a committed "green" company, all worker housing has been fitted with solar power, and water comes from our on-site reservoir. There are currently 300 full-time workers living on the plantation helping to ensure that we meet our initial goals, with this number increasing to 500 workers when the tea harvesting begins."
Plandai's other South African subsidiary, Green Gold Biotechnology, has been working to ready the manufacturing equipment and facility so that extract production can commence in time for the first harvest. "Green Gold is our business that is tasked with producing the extract from the live botanical material. The on-site factory is nearing completion and the equipment, which is being custom built in India, is in the final stages of testing.
Since our last Alert in May, PLPL has given traders some savory updates. The aforementioned future catalysts that are expected should have you smiling! If you bought on our May Alert, you are probably sitting pretty!
"We expect to ship the equipment in April and have the factory commissioned by August 2013."
"Short term," Mr. Duffield concluded, "we need to commence production of our Phytofare™ extracts and begin selling. To this end, we have finished with our product profiling and are
aggressively working towards having our full-scale production operational by the end of the year."
"As you will see, PLPL sets goals and then THEY ACCOMPLISH THEM. GOALS HAVE BEEN MET!"
"The farm is moving along at a rate of knots, so quickly in fact that they will be ahead of schedule and with more tea ready to be harvested than predicted. The factory is almost
complete with the machinery arriving from India over 4 shipments (the last two shipments are 15, 40ft containers each!). So in South Africa it really is all hands to the pump and I
can only look on in admiration at the all the hard work and effort that is being put in by the team out there."
As you may have seen, Plandai signed an exclusive license agreement with a UK firm – Phyto Nutricare PLC to market and sell all Phytofare TM products and they have been blazing a trail with three agreements already signed: www.phytonutricare.com
1 – NutraGenesis (North America)
2 – Willows Ingredients (Europe)
A Recent PLPL Release proposes the European Market could be the Icing on the Cake creating Valuation Appreciation. In a 2012 study, the market research firm Transparency Market Research, (TMR) estimated an annual growth rate of 6% for the worldwide nutraceutical market from 2012 to 2017 with a market size of nearly $205 billion by 2017. According to the study, Eastern and Western Europe combined will represent the third largest market behind the U.S. and Asia. Performing some quick interpolation from the data from the two market research firms, an estimate for the overall European market around $55 billion in 2017 can be inferred.
3 – Natural Products (South Africa)
Many more are in the pipeline and by the time product is ready for market, the market will be set and ready for a range of products that WILL change the industry!!!
PLPL has been BOOMING with NEWS since April 2013 giving Credence to the lofty Valuations and Goals the company has imposed on itself. Let's look at the developments from early 2013 that set the stage for where PLPL is positioned as a corporation.
Phytofare™ Catechin Extract has proven effective in killing the malaria parasite, plasmodium falciparum, in analytical tests developed by and conducted under the supervision of Dr. Sanjeev Krishna at the Division of Cellular and Molecular Medicine, Centre for Infection, St George's, London School of Medicine.
This study involving Phytofare™ is the first to show the effectiveness of using a commercial botanical extract, rather than purified extract of EGCG catechin, as an anti-malarial.
"We believe these results validate our decade-long research into the opportunity for using botanical extracts as a means to combat one of the world's great plagues."
600,000 die of the 5MIL infected with Malaria annually.Once all the current and proposed testing results have been evaluated, PLPL will submit its application with the US Food and Drug Administration to commence Phase II human clinical trials. PLPL is POSITIONING ITSELF to be an ORGANIC-based Leader in the fight against Malaria with the blessing of the FDA.......YES THIS IS HAPPENING!
Another Huge Growth Market is now being offered a Safer, Alternate means of Proven Medicine to combat Sports Injuries in the face of Time Constraint!
DISTRIBUTION Agreements are the name of the game if PLPL wants to evolve from Researcher and Product Innovator into a stable EARNINGS entity with reinvestment opportunities and surging sales. PLPL has pulled off SEVERAL Agreements that have Shareholders Blushing with excitement. Per the CEO Blog, we have established how Bright the Distribution Future IS and the Present Nature of the Agreements.
Phyto Nutricare will pay Plandai a one-time license fee of two million dollars (US$2,000,000) and then a recurring payment equal to five percent (5%) of future profits from Phytofare™ product sales. Sales of Phytofare™ are expected to commence in Q4 of 2013.
Phyto Nutricare is tasked with introducing our products to market in the nutraceutical arena, which covers supplements, food and drink additives, cosmetics, healthcare, and related fields. This is a multi-billion dollar industry that has heretofore been plagued by ingredients that suffer from a lack of bioavailability.
Licensing allows for PLPL to concentrate on product creation and to maintain flexibility.
Equipment is expected to be installed and ready for first harvest later this year!!
As you can tell, PLPL has been Checking off Goals on their business to-do list in quite spectacular fashion. As new product lines have been generated and testing initiates on different ailments, PLPL has now readied itself for sales explosions by signing with the appropriate Marketing and Distribution Companies both in North America and Europe.
The Present and Future have never looked better for PLPL!!!
PLPL knows its Proprietary Process for capturing such high Bioavailability Rates is worth its weight in gold.
PLPL is releasing a gamut of High Absorption-Rate Products into the market. Plandaí Biotechnology will bring to the market a scientifically improved, more bioavailable line of products. To accomplish this, Plandaí will put on its lab coats and employ a patented extraction process that allows this biotech to beat its competition. This process begins with the first product the company will bring to market, Phytofare™ Catechin Extract.
The Northern American and European natural extracts market are emerging and in a state of intense competition. The shift towards natural ingredients is driving the expansion of
the natural extracts market. Among the flurry of ingredients competing in the natural extracts market, green tea extracts is a pioneer and one of the most prominent success stories.
Why is PLPL so confident they will grab market share and shock clients with their product line in comparison to others? BIOAVAILABILITY!!!!
In the market today, green tea high purity EGCG extracts, with an average selling price of $500/kg, have poor bioavailability of between 1-10%. PLPL proprietary plant extracts have shown, in published studies, to have increased bioavailability. PLPL believes through their studies that this is between 60-80%, far exceeding anything currently available today!!
PLPL is in control of the ENTIRE Business process.They FARM the Raw Plants in South Africa, and then once harvested, quickly pass the live plant materials on to the next phase of the process. They create the Extracts in-house and develop business partnerships to properly Market and Distribute the end-product to the right consumer base.
According to the PLPL Business PLAN,PLPL has been targeting a Gargantuan ~$27MIL in sales by the first Year of full-throttle Business and ~$90MIL by 2020 in Profits.
Green Tea is a HIGH Growth Rate Market seeing annual volume growth rates of 13%-14%!!!
How does PLPL separate itself in the booming Nutraceutical Industry?
PLPL intends to transform the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market. PLPL is a Globally Diverse Player with headquarters in Seattle and offices in London and Nelspruit in the province of Mpumalanga, South Africa. This enables PLPL to react more efficiently to any worldwide market changes as well as to any customer requirements.
Currently, PLPL has 3 Defined Projects In Progress:
Senteeko Estate - PLPL farms a whole fruit basket of produce which it uses in its creation of highly bioavailable extracts, ranging from citrus to avocado pears to most notably over 2000 acres of tea. The tea plant, Camellia Sinensis, is an evergreen shrub or tree and can grow to heights of 30ft though for cultivation is pruned to heights of 2-5ft. http://www.plandaibiotech.com/images/Senteeko-2011-067.jpg
Green Tea - Green tea is one of the most widely consumed beverages in the world, second only to water, and its medicinal properties have been widely explored. The tea plant, Camellia Sinensis, is a member if the Theaceae family and black, oolong and green tea are produced from its leaves. It's an evergreen shrub or tree and can grow to heights of 30ft though for cultivation is pruned to heights of 2-5ft.
Gallate Catechin Extract - Polyphenols found in tea are more commonly known as flavanols or catechins and comprise 30-40% of the extractable solids of dried green tea leaves. There are 8 catechins in green tea. In lay terms: A number of the catechin polyphenols that are abundant in tea are reputed to have pharmacologically active properties. Within the plant, catechins are purported to be involved in the defence against pathogens, including insects, bacteria, fungi and viruses.
"While research into commercializing a citrus complex containing limonoids has stalled in the past, Plandaí intends to be the first to enter this market with a high-purity and water-soluble citrus complex once supporting human clinical trials are completed.
PLPL is a glimpse into the FUTURE of Extract-based Organic Medicine.
Technology and Research is finally catching up with what Nature has to Offer, and we are finding that some of the most gruesome and fearful medical dilemmas of modern times are being wrestled into submission by the powers of Bioavability and organic extracts. PLPL has an incredibly bright future ahead, and Patience is all that is needed for Sales to Grow and Valuations to be increased. In Late March, PLPL kissed $.05-$.06 goodbye and Marched bit-by-bit in an impressive manner to $.60 making short pit stops at $.18 and ~$.30 along the way.
PLPL chart has been on an unbelivable uptrend since the end of March. PLPL may be in the midst of a 2nd Wave up as the Chart catches its breath at ~$.60. Look at the DAILY CHART. Recalling all of the Positives in Place and the Future Catalysts coming into view, PLPL is ready to Explode Again!
Accumulation/Dist. is Surging on huge investor buying, and MACD remains Positive after a bounce back.
Support Rests at the 20SMA at ~$.46 while Resistance is in place at the 200SMA at ~$.81. A run TO the 200SMA would net shrewd traders a quick ~33% gain.
PLPL is aiming for $27MIL in Sales in 2013 and $90MIL in Profits in approximately 7 years. Along the way, patient investors may see GAPS occur as Contracts, Positive Testing Results, and New Products/Partnerships are procured. $1-$5? What is your Target? In these Monstrous Growth Industries, the sky is the limit.
With the start of major commercial production and sales of its flagship product, the total formulated Phytofare™ catechin complex, slated to occur sometime in early-1Q14, this sleepy stock will be generating meaningful revenue as well. All of these events serve to lower the risk profile, add to the already attractive valuation, and serve as a catalyst to drive the PLPL shares to new highs.
PLPL is the kind of chart that investors look at and think "it can't go any higher"....... and then it does. The chart has proven that theory twice now with consolidation and upward movement. The first profit taking has happened, and now we could be in for a wild ride. Start your research on PLPL right away as this could be an explosive opportunity.
Remember, trade smart, use stop losses and if you happen to see yourself in profits, it could be
wise to take advantage of the situation.
Spy Hard, Profit Easy
Dislcaimer: Stockchat LLC has received Ten Thousand Five Hundred Dlrs for the awareness of PLPL by a non-controlling third pary Berkshire Capital LLC Stockchat LLC has previously received Three Thousand Dlrs for the awareness of PLPL by a non-controlling third pary Berkshire Capital LLC
Over the past week, FRTN has seen a meteoric rise from $.50 to a high of $1.25. After a pullback to the $1-$1.15 zone, we feel that FRTN offers a Great upward risk/reward scenario with RSI remaining bullish just above 50 and not overbought.
This communications system integrator has been snatching up industry companies and expanding their reach, services, and value. In the last 2-3 months FRTN has progressed through various corporate administration and growth events. With an OS of ~10.2MIL and Float of ~1.34MIL, Traders are giddier than ever that the near future may be presenting them with some Serious Profits!!!
CCI-Telecom, Inc. is a leader in the Telecom equipment industry serving over 1,000 clients with the Avaya unified communications products. CCI-Telecom (http://www.ccitelecom.net/) has strategic alliances with Windstream (WIN) and Peatec.
"The combined client mix of the companies coming together will allow us to cross fertilize our different product disciplines within our existing client databases. CCI has an excellent reputation in the industry, Fortune 500 clients we didn't already have and a solid proven business model", stated Doug Rink.
Mr. Rankin's responsibilities will include the management of the telecommunications integration teams, new product and service development and customer relations.
He originally started selling telecom systems in in the late 1980's and in 1991 founding General Communications a privatized payphone company he sold in 1997. In 1993, he founded CCI-Telecom, Inc., developed for the retail wireless mobile phone business and later diversified into the telecom equipment business. At CCI's peak, he had grown to 5 retail stores and 50-employees andwas a leader in the Charlotte North Carolina markets in sales from 2002 to 2007 for Sprint Nextel Corp. (NYSE:S) eventually selling the wireless division in May 2012.
FRTN is a leading communications system integrator through it's subsidiaries, The New Telephone Company, Inc., CCI-Telecom, Inc., B & L Telephone, LLC and Fortran Communications, Inc. Fortran Corp. is dedicated to designing, sourcing, implementing and maintaining today's complex communications solutions for business and governments.
Just how big has this previously unknown, growth stock become?
FRTN services more than 3,000 clients in 2 states with 3 offices in the southeast. To learn more, please visit the Fortran Corp. website at www.fortrancorp.com.
What plans does FRTN have to grow?
FRTN's primary plans include organic growth within its existing customer base and acquisitions and mergers with strategic partners that will allow for continuous quality service and growth to maximize its value to all stake holders. Douglas W. Rink, President and CEO, of FRTN states that all of the companies and employees involved have had an integral part in this monumental endeavor to re-create our organization into a company that is positioned for exciting and aggressive future growth.
Let's take a look at one FRTN Subsidiary to learn more about what they do and what makes them unique.
B & L Telephone is a telecom player out of Hickory, North Carolina. You can learn more about them by visiting their home page here http://www.bltel.com
B&L Telephone provides a wide range of services to help business communications. Full details on the Products and Services can be seen HERE. The services are as follows:
Servicing Existing Business Communication Equipment, Voice/Data Cabling, Servicing Existing Surveillance Equipment, and a Free Needs Analysis.
FRTN Subsidiaries commonly sell the NEC product line shown HERE. Yes they are dealing with the Best-of-the-best in this booming industry! You can witness their Product Support and NEC details via the respective Link. Details on their other subsidiary The New Telephone Companycan be found HERE.
With THIS SHARE STRUCTURE, FRTN could be on the Verge of an Astronomical, VERTICAL Move!
FRTN has seen some excessive Valuation Growth and Price Appreciation as their growth strategy is implemented! Investors are taking notice, and many believe this is the beginning of something beautiful!
The price has doubled in a week as volume has picked up since June on the heels of News and Developments.
The Bollinger Bands have broken past $1.5, and RSI remains above 50.
FRTN may be due for another run of 50%+ in the near future.
There is no telling when we may see another Key Acquisition or Service expansion from this modern telecom trade! You have to be in it to prosper, and we feel that FRTN may be ambitious and motivated enough to continue to divulge HUGE Corporate Growth Developments in 2013. Always remember to do your Due Diligence to the fullest, and Trade Wisely!
Disclaimer: Stockchat LLC has been compensated fourty thousand free trading shares by a non-controlling third party Axis Partners for a one month marketing and awareness campaign which is set to begin on 8.19.13 for the benefit of FRTN. Stockchat LLC expects to receive future compensation via free trading shares for the ongoing awareness of FRTN. Stockchat LLC reserve the right to liquidate and or add to our position before, during or after the release of this report. Liquidation and or adding to our position will be done without notice to any individual, party or reader.
Stock Chat LLC has purchased four thousand five hundred shares of FRTN on the open market totaling forty four thousand five hundred shares. Stockchat LLC reserve the right to liquidate and or add to our position before, during or after the release of this report. Liquidation and or adding to our position will be done without notice to any individual, party or reader.
Biotech Engineering has led to some of the Best Inventions and Small-Cap TRADES over the last decade.
Some of the Most lucrative products ever are simple medical device inventions that can be used in the most common of medical situations - surgery, trauma care, invasive tecniques, etc.
ARTH is one such company that now has a Keystone Product being developed and commercialized to help both the medical world/patients greatly and could make investors profits as well!
ARTH is a New Trade with a New Business Plan. In late June, ARTH consummated the Reverse Acquisition Merger and thus entered the Life Sciences Industry whereby they adopted the Business Plan of Arch Biosurgery! Their Flagship Product is AC5™.
New Trades with Fresh Charts having little volatility of late can be Very Exciting when a Plan is Being Hatched. ARTH's situation offers money to be made through licensing/patents, acquisitions, and your basic sales in a Freaking HUGE TARGETED MEDICAL MARKET! Read through the Hemostatic Market Information, Market Scope, and then let your Jaw Drop! ARTH has skin in the game, and you can too!
The ARTH Chart is flirting with ALL-TIME Lows, Volume offers Great Liquidity for Traders/Investors, and we have an Imminent +MACD Cross and potential 20SMA Break to Boot! What a time to be here! The Average Daily Volume (3 Month) is now a MONSTROUS ~1.1MIL, and we have both Fundamental and Technical Catalysts in the Fold.
ARTH swiftly made several key moves to show investors their ambitious goals, appointed leadership roles across the company, attended conferences to build exposure, gave a corporate update involving preclinical testing, and last week announced plans for the rest of 2013 and early 2014!
If successful, AC5™ could make surgery faster and safer.? This means better surgical outcomes for potentially everyone, including you. You see the glowing potentials here - now let's take a closer look at these aforementioned developments to see exactly what ARTH has done! First we will look at the Recent Updates and Plans for Future activities, and then we will look at the company history and personnel that have been vital in spreading the ARTH message and product at various Summits and Conferences!
Arch Therapeutics, Inc. (OTCQB: ARTH) is a medical device company developing anovel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch's goal is to develop and commercialize products based on our innovative technology platform that make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate known as AC5™ is being designed to elegantly achieve hemostasis in minimally invasive and open surgical procedures. Find out more at www.archtherapeutics.com.
ARTH has devoted much of their work on its core technology to select the lead product composition, conduct initial safety and efficacy tests, develop reproducible and reliable analytical and manufacturing methods, and scale-up.
PATENT PROTECTION is HUGE. DO they Have it? How will they generate Cash Flow from Licensing? Don't worry. ARTH is covering their backside!
ARTH is focused on developing relevant intellectual property rights via filing several patent applications in multiple jurisdictions for self-assembling peptides and methods of use - all of which are pending.
Much of the pre-clinical work is a necessary pre-requisite to the clinical-regulatory program, which ARTH is currently designing.
What Benefits has the preclinical testing and data concluded?
The results of early data from preclinical tests have shown that AC5™ achieves hemostasis quickly and effectively. AC5™ can be directly applied as a liquid or sprayed, making it user-friendly and able to conform to irregular wound geometry, and is not sticky or glue-like, making it ideal for use in the setting of minimally invasive laparoscopic surgeries.
AC5™ is transparent, which should make it easier for surgeons or other healthcare providers to maintain a clear field of vision during a surgical procedure and prophylactically stop bleeding as it starts, which is called Crystal Clear Surgery™.
As a result of the consummation of the merger, ARTH commenced operations as a life science company pursuing the business plan of its newly acquired subsidiary, Arch Biosurgery.
In connection with the merger, the Company confirmed the appointment of Terrence W. Norchi, M.D. and Avtar Dhillon, M.D. as members of the Company's Board of Directors. In addition, Dr. Norchi was confirmed as President and Chief Executive Officer of the Company.
The appointments were made in a July 2nd release shown HERE.
A week later, ARTH Appointed Senior Management Team Members Mr. Alan Barber as CFO and Mr. William M. Cotter as COO.
As ARTH moves into this next phase of development, it is reassuring to know that capable hands are managing the various obligations and future challenges.
As a novel biotechnology company, conferences, literature, and interviews can be key in building a professional brand name and telling the story concerning the product/technology that the investors and prospective partnerships will heed. ARTH has begun to do Just that.
The Keynote was titled "Translating Nanomedicine: Molecular medical devices from Nano Neuro Knitting to Immediate Hemostasis to Cancer Stem Cell Arrest"
What Discoveries and Advantages of he AC5 were presented to the Public? Just how Ingenious is this Product per the Keynote Address? We found the results to be OVERWHELMING!
Ellis-Behnke talked about his discovery of new molecular medical devices and how they will change medicine and the entire healthcare system.
"Controlling the healing process is critical for the recovery of any injury, especially burn trauma," Ellis-Behnke continues, "First a barrier must be created to stop bleeding. In a surgical setting, we've shown that we can stop bleeding in small and large animals in less than 15 seconds, in multiple tissues, as well as a variety of different wounds, using a self-assembling peptide that creates a barrier and incorporates it into the surrounding tissue to form an extracellular matrix. This is all achieved without clotting and we've found that it does not induce an immune response."
An added benefit of the nanomaterial is that it is optically transparent. "Placing it on a wound not only stops the bleeding quickly and creates a barrier; it also provides a clear view of the surgical field while operating through it."
"This technology will impact the operating room in a fundamental way through the reduction in procedure time, along with the ability to control the environment so operations can be performed in less than optimal conditions while maintaining surgical field integrity,"
"The time to perform an operation could potentially be reduced by up to 50 percent."
The Continuance of Attending and Speaking at well known Medical Summits concerning their field of expertise has become paramount for ARTH for numerous reasons. ARTH Views Participation at Forefront of Emerging Trends in Nanomedicine as Important to an Ongoing Strategy for Success!!!
Dr. Rutledge Ellis-Behnke, delivered a lecture titled "The Spider Effect, how the Immune System in the Brain can be Measured and Modulated with Nanotechnology"
Inflammation is a Mega-Market in the Medical World. Ellis-Behnke noted, "Inflammation is often only treated for two weeks. However, our work indicates that inflammation can last far longer than that before returning to a resting state, suggesting that inflammation needs to be treated far longer than was once thought. In order to modulate these responses, it is important to control the leakage of blood within and between tissue components as well as in the local environment. This can be accomplished with novel materials."
Many Partnerships and Industry Professionals have had published works and studies to bring ARTH and its Products to their current stages of success. Some of the most significant findings from Dr. Ellis-Behnke's studies have been published. Importantly, ARTH has further engaged both academic and private third party facilities in the United States, including in Massachusetts, and in Europe, including a successful collaboration with several parties at the National University of Ireland and the Royal College of Surgeons in Ireland, in order to further advance the technology to its current state.
Last week, August 6th, ARTH kept with maintaining transparency for its shareholders. They released Another Update flush with guidance. We love these new growth stocks that present the ultimate short and long-term trading opportunities. We love it even more when the consistently open their mouths and keep us in the loop! ARTH - Arch Therapeutics Announced Plans for Upcoming Activities
WHO will the End Users of AC5 be?
Arch Therapeutics CEO Dr. Terrence Norchi states, "We are thrilled to be moving ahead with the development of our core technology. We envision the potential future customers in the marketplace for AC5™ and related products will include surgeons and other doctors, government agencies, hospital and operating room management, ambulances and trauma specialists. These market segments, even taken separately, present meaningful opportunities for the Company."
The Industry is in Need of this Technology. The Surgery/Wound Market is on the rise as is the demand for respective Products such as the remedy being offered by ARTH.
According to a 2012 report produced by MedMarket Diligence, LLC, approximately 114 million surgical and procedure-based wounds occur annually worldwide, including 36 million from surgery in the U.S. We estimate that 20-25% of those surgeries are performed laparoscopically. Additionally, there are many minor procedures and operations that may not be included in those figures. Those surgeries and other procedures could benefit from sealants and hemostatic agents, as surgical and trauma patients are at significant risk for morbidity and mortality from bleeding and/or leaking body fluid.
As a result of this demand, use of hemostatic agents and sealants is increasing. According to MedMarket Diligence, the market for these products achieved approximately $3.4 billion in 2010 worldwide sales and is projected to reach $4.5 billion in 2013 and surpass $6.5 billion in 2017. Over two-thirds of those sales are for hemostats. The growth rate for sealants is even higher than that for hemostats due to a general lack of available products and potentially larger unmet need.
AC5™ will meet increasing demands, with anticipated market entry for use in laparoscopic, as well as open surgery. While open surgery represents the more established market for hemostatic agents, approximately one-quarter of surgeries are laparoscopic, and that number is growing. Many of the hemostasis products currently available do not possess certain features and handling characteristics that are ideal for the laparoscopic setting
Further developing and securing intellectual property rights.
Engaging a large scale manufacturing partner to produce cGMP product for clinical trials.
Participating in EU and, subsequently, U.S. regulatory meetings.
Preparing for initial clinical trials, including developing clinical trial protocols.
Conducting formal biocompatibility studies.
Commencing human clinical trials.
Look at the Daily Chart. The Story only gets better from here! ARTH as a mere ~66MIL OS, and Volume has been coming in to the tune of ~1.1MIL Shares being traded.
This is REAL MONEY being invested here - ~$300,000 to ~$3MIL+ and much, much more on any outlying Volume Breakout Days!
A +MACD Cross looks to be happening ANY MOMENT Now. It is one of the BEST, if not the Best, TA Indicators to track.
The Last One went from ~$.90 to ~$1.4 - A Gain of ~55%!!!
Resistance is at the 20SMA - $.52. A Break and Hold could send it to the logical initial target of $.74 - the 50SMA. This could make your investment 42% richer!
Other targets May be the previous Channel Base of ~$.80 and the Recent All-Time High of $1.4. Runs there could net you 53%-169% Gains.
You have to Love finding NEW Stocks like this that have a Potential BLOCKBUSTER Product in a TITAN of an Industry - Biomedical Products and Technologies. Whether ARTH is a Buyout/Acquisition Target, they achieve profitable licensing/royalty scenarios, or they secure all necessary patents and go it alone with the help of a few key partnerships - it has become clear that they are in a BEAUTIFUL Position!
The Price could be at rock-bottom, and yet the Future has never looked brighter!
Start your research on ARTH right away as this could be an explosive opportunity.
Remember, trade smart, use stop losses and if you happen to see your self in profits, it could be
wise to take advantage of the situation.
Spy Hard, Profit Easy
Disclaimer: Stockchat LLC has recieved Three Thousand Five hundred dlrs for the awareness of ARTH by a non-controlling third party One22media LLC
After a 200%-300% SURGE to ~$.014 Last Week, BYSD is gaining tremendous investor interest on a pullback to ~$.005.
Several Mid-to-Late July Press Releases have awoken this Domestic, Small Cap Oil & Gas trade!
With so much to gain in quick measure, let's see what has caused all of this hullabaloo. Our Traders LOVE making multi-bagger Returns, and BYSD seems to be in a great position to just that after a flurry of releases and a pullback to previous prices! Partnerships, huge purchase orders, share reductions, and more have ignited the flame. Is a Fiery Return coming? Let's look at some of these Corporate Developments in depth.
Under the agreement C-Trade Group, Inc. will help to provide financing and contract support in the form of monthly bank guarantees in the amount of $160,500,000 for international heavy fuel oil exports.
The 2 have a previous history of Success?! You betcha!
C-Trade Group and BYSD have previously worked together successfully under a joint venture financing agreement for the redeveloping of existing oil fields using today's technology to restore and access more production from wells that were drilled 30 plus years ago.
The Board of Directors has approved the cancelation of 1,400,000,000 authorized capital (common) stock effective immediately. This action is to reduce the authorized capital from 3,400,000,000 to 2,000,000,000.
Clearly the Company is Committed to CREATING SHAREHOLDER VALUE!!!!
Bayside Corporation is an energy exploration, development and production company building oil & gas reserves and production in some of the most prolific hydrocarbon bearing regions of the United States. The Company specializes in the business of reworking & re-completing 'marginal' oil & gas wells located in the thousands of mature oil & gas producing fields across much of the United States. For additional information on the Company visit our website at: http://baysidepetroleum.com
What does the company have to say about the expected International Growth facing BYSD and its shareholders?
Gordon Johnson, Chairman of Bayside Corp., was quoted saying,
we are thrilled to expand our revenue base with international heavy fuel oil export orders."
Furthermore, the contractual finalization of the purchase orders and the heavy fuel oil exports is expected to be completed within the next 30 days. Domestically speaking, the timing has never been better for companies such as BYSD! "With approximately 20 percent of American oil production and 10 percent of American natural gas production coming from marginal wells, they are America's true strategic petroleum reserve."
Yes the Market at home is Ripe for the picking? BYSD stands to benefit greatly!
420,000 Marginal Wells in the U.S.A. add up to a Lot of Oil & Gas! BYSD believes that the proven reserves contained in aging oil & gas fields represent a key early step in reducing the nation’s current dependence on imported oil. Marginal wells produced more than 335 million barrels of oil in the United States in 2006. That's equivalent to more than 60 percent as much as the United States imports annually from Saudi Arabia and reworking of many of these wells can dramatically enhance their production volume!
Strong Management Teams are necssary to create a winning investment, and BYSD is on the right track!
Bayside’s management team is comprised of senior executives having an enviable record of success in the Oil & Gas industry. Particular strengths in Petroleum Geology, Exploration, Oilfield Operations & Rework technologies, Finance and Corporate Governance augur well for the Company’s intentions to rapidly build assets and production revenues by capitalizing on extraordinary opportunities in the business of reworking mature oil and gas wells. As required, the management team will be strongly supported by leading consultants in such fields as reservoir engineering and other Oil & Gas industry specialties.
Why are Wells so crucial and profitable at this juncture?
By reworking/remediating these wells, i.e. re-entering the well and replacing the clogged production tubing with new tubing, and applying other technologies such as ‘fracing’ and other EOR (Enhanced Oil Recovery) procedures, oil flow rates can be restored to maximum levels of production. In addition to this very attractive rework potential, some of the Company’s mature oil & gas fields also present potential for drilling offsetting development wells to further boost production from the field.
If a given oilfield contains sufficient recoverable reserves – and Bayside’s project selection process ensures this by confining its acquisitions and rework projects to those projects meeting minimum proven reserve requirements and other technical prerequisites – rework procedures will generally succeed in dramatically restoring flow rates, thus boosting oil production by more than an order of magnitude. (From 15 bbls/day to 200 bbls/day+ on many of Bayside’s projects.)
What is the Near Term Project Outlook for BYSD?! It is more exciting than ever!
To date Bayside has assemble interests in, and it drilling, re-completing and/or reworking a valuable portfolio of 13 properties in oil and gas fields throughout Texas and Mississippi. The properties contain 58 wells productive well bores and 4 saltwater disposal wells. The productive well bores are candidates for rework and/or re-completion. Also, there are numerous development drilling locations remaining on these projects. Upon completion of the work proposed on the properties now inventoried the Company should have proven, discounted future net revenues exceeding $10 million with undiscounted future net revenues approaching $20 million. The Company has an aggressive growth strategy with a goal to reach net proven reserves of 10 million barrels of oil equivalent within 12 to 18 months of pending funding. For Oil and Gas FIeld Projects Please visit their Project Page - http://baysidepetroleum.com/contents.php?page_id=13. For Industry Developments and Updates head over to http://baysidepetroleum.com/contents.php?page=6.
At such a cheap price, with so many projects on tap, and so many Developments occuring in the past 10 days, BYSD is in a perfect position to be capitalized upon! Look at the DAILY CHART as BYSD rests half a cent!
Support rests at $.004 at the 20SMA while Resistance is at $.005 and a current break and hold may cause a Price Explosion!
The next stop? $.01 is a logical target at $.01 - the 200 SMA - for a potential 100% quick gain.
A return to previous, recent highs at $.014-$.016 could cause an even bigger ruckus if traders snatch a quick 200% return!!!
MACD is still trending positive, and RSI is nearly bullish at ~47.
BYSD has caused a stir by releasing several progressive developments to the public. Additionally, this is THE INDUSTRY for a Small-Cap Energy Player to be in at home in the USA. For these reasons we think BYSD has positioned itself greatly to benefit shareholders - possibly Very soon!
Trade wisely, and continue to do your research. We hope you enjoy BYSD!
Spy Hard, Profit Easy
Disclaimer: Stockchat LLC has received Three Thousand Five Hundred Dlrs for the awareness of BYSD by a non-controlling third party One22Media LLC.
Small Capitalization Biotech Stocks offer some of the BEST, Hidden technologies and growth spaces opportunities.
Being UNIQUE and using real research and results to provide for a framework for FDA Trial advancement, blue chip relationships, and funding are crucial. Our newest trade is SURGING Near Recent Highs after Huge Medial Mariujauana Industry News and a BLOCKBUSTER Pancreatic Cancer Treatment Acquisition!! Since a run to a MULTI-YEAR High at $.22 in May, NVLX has STORMED near these zones via MONSTER VOLUME and a +MACD Catalyst clinching a breakout with NO End in Sight!!! NVLX has caught fire after a flurry of news, and traders are enjoying the uprends. What have we seen?
NVLX announced the completion of the acquisition of all of the shares of Bio Blue Bird AG ("BBB"), a wholly-owned subsidiary of SG Austria Private Limited (SGA). As a result of this acquisition, BBB is now our wholly-owned subsidiary.
BBB owns exclusive worldwide licenses associated with the live-cell encapsulation-based pancreatic cancer treatment. These licenses include worldwide rights to utilize the live-cell encapsulation platform technology to develop treatments for any and all cancer types, regardless of the cell type encapsulated.
The funding to complete this acquisition was secured through the sale by the Company to accredited investors of $1.5 million in restricted stock at $0.125 per share. The total purchase price for BBB was $1.5 million.
"The advantage to our shareholders is a reversal in what would have been an approximately 20% dilutive event of the total outstanding company stock if we would have acquired the SG Austria assets and personnel, as was originally contemplated."
"Now, because we acquired 100% of the BBB equity, the subsidiary with the technology licenses and assets, and a 14.5% interest in SG Austria, the Company and our shareholders have realized a substantial non-dilutive net gain because the 100,000,000 shares have now been returned to the Company's treasury."
NVLX has avoided a significant increase in anticipated operating expenses that would have been associated with the original Asset Purchase Agreement, saving critical capital for use in preparing future clinical trials.
Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, notes in a recent article on its website that Nuvilex Inc.'s (OTCQB: NVLX) recent acquisition of all of the oncology-related assets and licenses for the use of a live-cell encapsulation therapy serves as a catalyst to accelerate the research engaged by its subsidiary, Medical Marijuana Sciences, Inc.
Management may elect to study the effects of multiple cannabidiol (CBD)-based cancer treatments. These studies would seek to combine the Company's highly efficacious live-cell encapsulation-based therapies used for oncology therapy, with therapies based on cannabidiol.
Is this the RIGHT INDUSTRY TO BE IN?! YOU BET! The medical marijuana arena is enjoying a great deal of attention and a growing cadre of investors and entrepreneurs as many prognosticators forecast huge revenue growth over the next 3 years as more states pass medical marijuana legislation. For example, independent financial news and data firm See Change Strategy estimates that the U.S. medical marijuana market is worth $1.7 billion and could reach $8.9 billion by 2016.
How is NVLX unique? Where do they separate themselves?
NVLX has a "cell-in-a-box" therapy using their live-cell encapsulation technology.
Timing is CRUCIAL for making biotech trades quickly lucrative. Now is a great time to look hard at grabbing NVLX. The company has an upcoming Phase III clinical trial studying its treatment for patients with advanced,inoperable pancreatic cancer. A Successful result could mean Monstrous gains for shareholders.
With a great deal of excitement surrounding this company's technology and the amazing results it's shown in clinical trials against advanced pancreatic cancer and in pre-clinical studies in diabetes and against mammary tumors, there are many new investors taking a look at the company.
NVLX is diversified in targeting diabetes, pancreatic cancer, oncology patients, and the company is advancing the study and use of medical marijuana - a BOOMING Industry.
Nuvilex Inc. (NVLX) is an international firm with a live-cell encapsulation technology initially directed to treat pancreatic cancer along with the development and study of the use of medical marijuana for the treatment of oncology patients.
Nuvilex, Inc. has been a provider of all-natural products for many years, has expanded its company to increase its natural product based footprint through medical marijuana studies and is becoming an international biotechnology provider of live, therapeutically valuable, encapsulated cells and services for treatments, research and medicine. The Company's offerings will ultimately include cancer, diabetes and other clinical treatments using the company's natural product knowledge, product base, cell and gene therapy expertise, and live-cell encapsulation technology in addition to other new products currently under development. For more information visit: www.nuvilex.com
NVLX has a Phase II Trial on the backburner along with a Phase III for treatment of Pancreatic Cancer.
The Firm has established a research cell bank in concert with a leading contract research organization in Europe. This cell bank will be used for the production of the Company's live cell encapsulation offering, which has demonstrated significant ability to activate the cancer pro-drug ifosfamide in close proximity to the pancreatic cancer itself, thus resulting in a high degree of antitumor efficacy with a low toxicity profile for the anticancer drug, in Phase II clinical trials.
Validation from these well-regarded third-party sources and the launch of the cell bank indicate that Nuvilex is on the cusp of making significant progress toward the initiation of various cancer clinical trials, most importantly the late-stage pancreatic cancer trial, given the devastating and deadly nature of that disease.
Cancer Treatment results for NVLX have been STELLAR!!!!
Two key results pulled from the data of those trials, are that the median survival rate was higher than that of the current gold standard for the disease and better than those of other competitors' treatments when clinical trial reports are examined. Furthermore, the overall side-effect profile (toxicity) was much lower with Nuvilex's treatment than those of competitors' treatments.
KnockOut Technologies is the Nuvilex Division Responsible for Progress in Research and Development in the Natural Product Space.
Products that work effectively can also be safe for the environment, and this is the premise behind the products being developed by Knock-Out Technologies. Our products are being carefully researched and developed for both safety and effectiveness.
NVLX may be seeking and being sought after by some large pharmaceutical companies. These collaborations often contain an agreement to assist in funding future research and development, a royalty arrangement should development lead to regulatory approval, and occasionally lead to a direct investment in the targeted company itself.
When it comes to pancreatic cancer, you can bet the NYSE's Eli Lilly and NASDAQ's Celgene Corp. are all too familiar with Nuvilex and its technology.
Currently, Eli Lilly's drug Gemzar is the only drug to date approved by the FDA as a single agent for the treatment of advanced, inoperable pancreatic cancer and the drug is considered the "gold standard" by the market. Eli Lilly introduced gemcitabine (Gemzar) back in 1996, and since that time, it has netted the drug's maker billions of dollars in sales.
Nipping at Eli Lilly's heels are both Celgene and Nuvilex, but of the three, the smallest of them all, has produced the best results in clinical trials using its living cell encapsulation. Nuvilex's "Cell-in-a-Box" is a process that forms a "platform" upon which treatments for many serious, debilitating, and even fatal diseases may be built. Some of these diseases include different types of cancer, diabetes, diseases for which stem cell therapies are being developed, and diseases caused by viruses.
In early May, NVLX was discussed in a research report. Some very important corporate details surfaced and represented the positives and upside potential that this equity holds -
Nuvilex's "blockbuster" cell encapsulation technology for cancer, diabetes is a "true platform that could benefit countless indications;"
Nuvilex's Phase I/II clinical trial data outperformed today's "gold standard" for pancreatic cancer;
Diabetes drugs could potentially be eliminated by Nuvilex's cell encapsulation technology; and
Nuvilex's subsidiary Medical Marijuana Sciences and the adaptation of the living cell technology into the medical cannabis industry
The other Industries and corporate targets may seem more flashy, but some feel that Diabetes medical advancements may be the most illustrious accomplishments garnered by NVLX.
By 2020, the market for diabetes treatments is projected to reach $65 billion worldwide. According to the International Diabetes Federation, 371 million people around the world have been diagnosed with diabetes and another 187 million remain undiagnosed -- leaving many millions susceptible to the debilitating, and even deadly, complications associated with this disease.
Other Markets are being aggressively targetd by NVLX therapies and technolgies!
Since great promise has been demonstrated in its preclinical breast cancer studies, it is possible that trials to treat the $10 billion breast cancer market are next on Nuvilex's list.
Each year, 230,000 women in the U.S. are diagnosed with breast cancer. Interestingly, some of the FDA-approved treatments for breast cancer are being studied now to treat pancreatic cancer. However, to date, some of these treatments have demonstrated lower efficacy and survival rates in pancreatic cancer patients than with breast cancer patients.
NVLX hopes to commence human clinical trials using medical marijuana to treat cancer. These events will place Nuvilex, at the forefront of both the medical marijuana and the oncology treatment arenas and could serve as one of the drivers that limit the off-label use of chemotherapy.
An estimated $12 billion was spent on chemotherapies in 2010, with up to $4 billion on off-label use. Clearly, as the numbers bear out, physicians are scrambling to seek complementary alternatives to be used in conjunction with or instead of FDA-approved therapies that may not be working alone.
Nuvilex's subsidiary, Medical Marijuana Sciences, Inc., builds upon the Company's many years of experience in developing "all-natural" products for various uses by studying the medical applications of marijuana (Cannabis sativa) and developing treatments for serious human diseases.
NVLX is a Dream-like stock for the Biotech Trader looking for a short and long-term trade that has a Diversified Portfolio of Technologies and Therapies that are rapidly advancing.
Start your research on NVLX right away as this could be an explosive opportunity. The last RUN went to $.22, but that was BEFORE NVLX RETURNED 100 MIL Shares and Made a BLOCKBUSTER Pancreatic Cancer Treatment Acquisition!
If you look at the DAILY CHART, you will notice the Incredile Liquidity that NVLX offers ranging around $400,000 being traded on days like these.
Support currently rests at the 20 and 50 SMA's at ~$.13.
A recent Run to $.22, could mean we see a RETURN THERE OR MUCH HIGHER given what has transpired in June-July!
+MACD Cross is Very Bullish for NVLX Traders as is the Trending Accumulation from investors!
Remember, trade smart, use stop losses and if you happen to see your self in profits, it could be wise to take advantage of the situation.
Spy Hard, Profit Easy
Stockchat LLC has received three thousand dlrs for the awareness of NVLX by a non-controlling third party. Stockchat LLC has previously received three thousand dlrs for the awareness of NVLX by a non-controlling third party.
If you have been following my alerts you know I am crazy for bottom bounce charts.
We try to spot them when indicators are about to give us the reversal indication but at times we find them
at their prime moment.
ITKH is at that moment as the MACD is perfect, I repeat perfect.
Let me explain:
MACD - Is at maximum distance from the zero line, a very bullish trend, and found bottom two trading days ago and is now curling up to do a bullish cross over with the signal line.
"If you have ever wanted to see the perfect macd, this is it. IMO"
RSI - Sitting in over sold territory, a very good sign for entry points and has plenty of room for multi day up trends.
Price is near the bottom bollie resting at a support line which has launched of two previous runs: June 25th to June 27th for 100% and July 9th to July 12th for 50%.
ITKH chart is at its prime moment, and this could be the week for the next uptrend.
iTeknik Holding Corporation was formed to develop and launch new technology and products in the global communications market. Through its Send Global subsidiary, iTeknik provides wholesale and retail telecommunications
services, and products worldwide. Its services include voice over Internet protocol origination and termination; A-Z routing and switching; wholesale carrier routing services; reseller billing and reporting; Web-based reseller
solutions; prepaid calling card solutions; international cellular calling; and retail point of sale solutions.
Fredrick W. Wicks, Chairman and CEO of iTeknik Holding Corporation, stated, "We have worked hard to improve our financial results for three straight years. Our plans for FY 2013 will be designed to continue our expansion and focus on our profitmargins. We have expanded our product offerings to include three new so-called 'hard' products, Subscriber Identification Modules for mobile phones, DataJack™, which is a Wi-Fi hot spot available on the nationwide Sprint 3G wireless network, and mobile broad brand routers. In addition, we are expanding our Agent network and we have modified our proprietary EZposa retail store interface so we can easily add independent stores to our three thousand plus store network."
The Chairman's Letter provides detail on iTeknik's:
Continuous Improvement Program that resulted in a 5.0% decrease in operating expenses
FY 2013 Agent Expansion Program
On-going Capital Structure Improvement Program
Product Expansion Plans
Strategic Plans for growth through merger/acquisition
iTeknik Holding Corporation (PINKSHEETS: ITKH) is classified as "Current Information" and trades on the OTC Pink tier of the OTC Market. For real time quotes and market information on the company visit http://www.otcmarkets.com/stock/ITKH/company-info.
Start your research on ITKH right away as this could be an explosive opportunity.
Remember, trade smart, use stop losses and if you happen to see your self in profits, it could be
wise to take advantage of the situation.
Spy Hard, Profit Easy
Stockchat LLC has not received any compensation for the awerness of ITKH.
It is one of the most Unique Publicly Traded Business models out there. Yet when you read the history books and account for the Population of Shipwrecks throughout the last several hundred years, you conclude that there are a vast number of cargoes still laying untouched in Davy Jones' Locker.
HUNDREDS of Ships spanning a century lay off Caribbean Coasts, in the Mediterranean, in the Northern Atlantic, Asian coastlines and elsewhere.
The Reward for such tedious ventures is Absolutely Stunning. BILLIONS OF DOLLARS in Gold, Silver, and other such precious Metals, Jewels, Porcelains and Artifacts lay in these once-powerful Seafaring and Plundering vessels.
INNO is one of but a Handful of companies seeking to extract and unlock the Incredible Value just waiting for them at shipwrecks, the majority of which are well documented and pinpointed. INNO has all of the ingredients to make it a best-in-breed industry trade, and at 7 cents traders are now fighting over shares!!!!
7 cents is Cheap given the last $81MIL find our INNO Leader hauled in. A few weeks ago we were trading 400% Higher, and traders are now accumulating shares betting on a reversal. CAN YOU BELIEVE THIS OPPORTUNITY? We can't!!!
The corporate metamorphosis switched gears in June with several key progresses. None were bigger than whenINNO Made a Golden Splash into the Niche Industry in Early July with This Announcement - Innocap Inc. Set to Begin Shipwreck Recovery Efforts. Multiple Shareholder-friendly motions have taken place in the past 2 months that may set this stock ablaze as as attentions are grabbed and buying picks up:
Circadian will make certain Investors are well communicated with through "one-on-one" attention complete with rich and effective marketing materials. Also, the firm will create a "pull style" financial marketing campaign aimed at constantly creating new interest in the company's stock.
As a rather New Equity, INNO shareholders stand to benefit greatly from increased liquidity, a growing shareholder population, the utmost transparency, and loads of media attention.
Timing has never looked better for INNO Traders. We consider ourselves lucky for finding this stock at this juncture! Details of this Analysis can be found below, and boy are they SIZZLING!
With Previous discoveries worth ~$81MIL, and current projects near the Philippines targeting MILLIONS MORE, it is easy to see why an OS of ~106MIL and Market Capitalization of Under $7.5MIL can be deemed as Miniscule. INNO is targeting Hundreds of Millions of Dollars in Marine Recoveries.
After falling from its recent $.20-$.38 trading range to a MERE ~$.07, INNO Now Offers an absolutely Stunning Trade. These discoveries are becoming more commonplace, and if INNO is next in line for a major haul, then we may be kissing these prices goodbye forever!!! WIth around $70,000 volume traded today, INNO is showing Vastly Increasing Liquidity as Traders try to take advantage of these cheap prices.
Innocap, Inc. (OTCQB: INNO) is a marine exploration company specializing in research and development of ocean recovery projects.
The Company's research has shown there are many shipwrecks around the world which contain valuable cargo.
Innocap, Inc. will treat all shipwrecks with respect and have archeological assessments on each qualified shipwreck.
Innocap will utilize the latest technology available to enhance salvage projects.
INNO is a world class leader in deep ocean technology used to find, salvage and bring historical impact from their deep sea projects. With over fifty years combined experience, the dynamic duel leadership of Paul Tidwell and Chris Dubea complement each other's strengths to bring this company a broad spectrum of opportunity on the high seas. Dubea's knowledge and experience in marine engineering, development of specialized equipment, notably the ROVs (Remotely Operated Vehicles), and his network of corporate and government agents who know and respect his leadership, team approach and successful project experience, alongside Tidwell's vision of the across the board value of each project from negotiation in countries around the world with governments of decidedly contrasting agendas, the ability to achieve the deepest salvage project to date, the respect and care of salvaging artifacts of great value, the marketing acumen to know the value and where to find the best exposure for such artifacts, but more intensely motivated to bring the full historical story of the people involved in the original mishap that brought about this treasure being lost to the sea. Tidwell's adventures have been documented by some of the most trusted authorities, such as National Geographic Magazine, NBC television and the Guinness Book of World Records (Silver Edition); presented in distinguished halls of higher learning and fictionalized ready for Hollywood movies, television documentaries, social media videos and even video games. This company is built on the knowledge and experience to handle deep sea projects from conception to final market.
INNO has a Best-in-Breed Industry Professional at the Helm.007 loves to stress that PEOPLE are what turn Small Cap Trades into Monster Returns, and INNO has the exactly what it takes to turn this growth marine recovery trade into exactly that. Paul Tidwell is a PIONEER with previous blockbuster project successes. History Repeats Itself!
Led by one of the most successful marine recovery pioneers, Innocap plans to engage in marine salvage operations in Asia and the Atlantic that combined potentially may be worth hundreds of millions of dollars. Innocap's founder, Paul Tidwell brings a history of marine salvage success. Tidwell located the legendary Japanese submarine I-52, the deepest marine recovery effort ever, in water 3 miles deep in the Atlantic which has 2 metric tons of gold on board worth an estimated $81M alone.
What is the state of the Current Projects Detailed on the Home Page and in the stage-setting July Release "Innocap Inc. Set to Begin Shipwreck Recovery Efforts"?
In addition to the I-52 project, INNO will soon begin salvage operations of a shipwreck located off the coast of the Philippines.
The ship, based on preliminary studies, appears to contain a cargo of Chinese porcelain made during the Ming Dynasty. Reportedly worth millions, INNO will be entitled to 50% of any cargo that is recovered from the salvage.
Innocap is a great story that has broad appeal among public and private investors and appears poised to now become a great stock. Led by a renowned leader in marine salvage recovery, Innocap offers huge upside via the potential value of marine salvage recovery cargo (i.e., treasure) with the I-52 project potentially worth hundreds of millions alone. Plus, Innocap is poised to enjoy other revenue streams related to post-recovery operations including film production, education, promotion, entertainment and exhibitions. This model is similar to Premier Exhibitions which is known for its Titanic salvage and other, unique nationwide exhibitions. As Innocap initiates the return to I-52 and engages in its other salvage operations and related ventures, we expect that the Company's valuation will increase substantially."
Innocap is negotiating an exclusive contract with a corporation located in the Philippines to commence a three-phase recovery of a shipwreck containing a cargo of Chinese porcelain.
The ship appears to be of Chinese Junk design and has been covered by mud for possibly hundreds of years.
Samples of the cargo have been recovered and identified as Ming Dynasty (1368-1644) porcelain.
The shipwreck potentially contains thousands of Ming Dynasty plates, teapots, and cups.
Research into the Chinese porcelain market indicates that Ming Dynasty, and other ancient Chinese porcelain, has reached an impressive increase in the investment and collector marketplace; and, therefore, the salvage of these highly prized artifacts as the Company’s top priority in the short-term. As Karla Klein Albertson, of the Auction Central News writes:
Prized by collectors and coveted by museums, Chinese export porcelain continues to be worth its weight in gold. In April, Winterthur in Delaware devoted its annual ceramics conference and exhibition space in the galleries to the popular topic as it revealed that yet another outstanding group of porcelain was destined for the permanent collection."
Upon entry into contract, as part of the preliminary recovery operations, INNO will utilize acoustic mapping equipment to map the outline of the ship and debris field. Additional samples of porcelain and wood will be recovered to further the identification process.
Innocap is also in discussions with Indonesia to search for the Flor de la Mar, which sank in a storm in 1511.
This ship is purported to have a substantial amount of treasure onboard.
Although Innocap cannot substantiate the full value of the cargo at this time, the Flor de la Mar it is said in many places to be the most valuable sunken ship. After a contract has been issued, Innocap will determine, to the fullest extent possible, the value of the cargo and the position of the famous shipwreck.
Innocap will further the historical research to study the documentation before hunting for the sunken vessel, consulting with prominent historians, Geologist, Remote Sensing Mapping, oceanographers, marine biologists, and scientists specializing in River Hydrology and Hydraulics, to name a few.
Additionally, Innocap is developing other salvage projects in Malaysia and Indonesia. Negotiations are ongoing in these countries.
007 is very excited about the INNO Trading Opportunity. The potential gains here are ENDLESS based upon just ONE Discovery Catalyst, and the price may very well trend 100%-400% higher in the meantime as these events and other developments take place and bring INNO back to its previous trading channels. Remember to Trade Wisely and to take some profits if they come - Ride out the Rest if you so choose! We dove into the deep end here, and we may end up unlocking a chest full of treasure!!!!
Start your research on INNO right away and remember, if you happen to find your self in profits, it could be wise to take advantage of it. Trade safe and enjoy.
Spy Hard, Profit Easy.
Stockchat LLC has received Eleven Thousand Dlrs for the awareness of INNO by a non -controlling third party.
GBEN is offering traders a chance at owning an Absolutely Unique, HYDROGEN-based technology at the ridiculously cheap price of around ~$.013.
Once you SEE Just how CRAZY this Innovative Hydrogen Fuel Cell Technology is you will begin to see why GBEN Management has such lofty expectations. They are in a BOOMING Industry with a Diamond of a Product Technology.
Management is SO BULLISH on their Product that they are calling for a MC of ~$32MIL and a ~$3.16 price per share. Think they are joking? Think again!
Global Resource Energy, Inc. (OTCQB: GBEN) is a development stage clean technology company interested in the development and commercialization prospects of new and innovative technologies aimed at creating a safer and cleaner environment while improving the health of the domestic economy. Sustainable growth is the cornerstone of the Company’s mandate and vision and Management embraces the convergence of environmental solutions and economic viability as a yardstick for stakeholder success.
Learn more about GBEN, its management team, Hydrogen Fuel cell information, industry news, and contact information at their Home Site - http://www.global-resource-energy.com/. Their Crowned Jewel Product/Technology is the MyCroft Fuel Cell detailed below!
What valuation is management targeting?
Try $3.16 with an EPS of $.316 and very modest, relative-to-industry, PE multiplier of 10.
Assuming the OS remains constant, and GBEN can garner a ~5% Market Share with their leading technology, then the Pro-Forma Statements are dictating $37.5MIL in Sales in this exponentially growing industry.
If you feel a 5% Market Share is lofty then do your own math and discover that even a .5% Market Share and drastically reduced Sales Performances STILL Show the current $.013 Price and $964K MC as a rare investment opportunity.
You do not often see equities with such small Share Structures, owning incredible Technologies and business plans, being priced at such measly numbers. Something has got to give!!!!! We are excited to see what the future holds for GBEN Shareholders.
Are you Freaking Serious! Do you know the RUN a 1.3 Cent stock can go on with this sort of Share Structure and Dirt-Cheap Valuation? GBEN may be leaving a Vapor Trail with sidelines traders left in the smoke when this is all said and done! Timing is key in trading -
Global Energy Resources Mycroft® Technology license may prove to be a revolutionary opportunity compared to the other concepts currently under development. As a niche market player utilizing maximum capital efficiency, Global Resource Energy, Inc. is poised for exponential growth and excellent returns for investors.”… The fuel cell industry is in a very interesting period. It is (slowly) transitioning away from being primarily an R&D-based industry to becoming a commercial industry. As part of this transition, normal industry consolidation is already being seen, with a number of companies going out of business or selling off intellectual property (IP).”
Interest is Spiking, and traders are optimistic that this Equity will see its $.013 price-tag return GBEN to more modest valuations incurred during its run to $.0275 less than 2 weeks ago - a 100%+ minimum return in a flash! This news has set the stage for GBEN Growth through partnerships in 2013.
Investors may recall GBEN sending representatives to last year's conference in Florida which resulted in key business contacts and important connections in the industry.
These relationships were both locally and internationally. It is expected that that GBEN representatives will enjoy similar successful networking and business opportunities in Brazil. The speakers are to include, I fly Serafirm, Senior Business Development Specialist, Electrical Power & Renewable Energy, International Trade Administration, U.S. Department of Commerce, also Tim Chambers, Marketing Manager, HydroVision Brasil & DistribuTECH Brasil, PennWell Corporation.
Brazil's investment rate is forecast to accelerate to as much as 25% of GDP within five or six years as the country's energy and power sectors expand to keep pace with the demands of economic growth. This follows the Government's launch of a large infrastructure program as Brazil prepares to host the two largest mega-events in the world, the 2014 FIFA World Cup and 2016 Rio de Janeiro Summer Olympic Games.
What is the MyCroft Fuel Cell?
The company has recently entered into an agreement with a license holder of a significant technology that shows extraordinary promise under laboratory conditions. The MyCroft® fuel cell is a ‘recirculating loop electric generator’ (R-LEG) which utilizes the motion of hydrogen within a sealed loop to create electricity that appears scalable to a wide number of commercial applications.
The system has been investigated with measured performance documented by researchers from a highly respected research and testing laboratory. Further research and development is underway with a number of potential outcomes that could prove viable within a relatively short period of time. The system is practical and effective and could be developed for small scale (micro power) medical applications with economies of scale eventually leading to industrial and residential applications.
What makes it different from the competition?
The MyCroft® Fuel Cell Technology differs
fundamentally from its competitors:
It’s an innovative and potentially gamechanging concept known as a Recirculating Loop Electric Generator (R-LEG)
While it requires a fixed quantity of ‘hydrogen fuel,’ to charge the system, the fuel is not consumed but sealed within a loop and ‘pushed’ across a catalyst to create electricity.
The system requires no ‘fuel’ other than a source of energy to move the hydrogen through the loop.
Anticipated Commercial Advantages GBEN has are the following:
Reduced mass (weight and volume)
Improved reliability (minimal moving parts)
Scalability by stacking cells (similar to a traditional fuel cell)
Significant fuel savings
What about Real Life Applications?
This is where Valuation is build and Sales are generated. GBEN has a great Share Structure and can get the funding they need, but where will shareholders see value creation from this technology in the market place?
Applications include but are not limited to:
Implantable Medical Devices – Prosthetics – Electric Vehicles
Manufacturing Facilities - Remote Sensing – Marine Power
Aerospace – Emergency Power – Public Transit
What vision does GBEN have for MyCroft and their own business model?
Global Resource Energy plans to optimize the management and development of the MyCroft® technology through a number of funding scenarios in a controlled and responsible manner in order to best capitalize on what, if successful, could be a truly disruptive technology able to significantly alter the current state of the industry and to bring alternative fuel cell technologies rapidly into the forefront of the burgeoning alternative energy sector.
Global Resource Energy Inc is a Clean Energy Solutions Company that seeks to deliver Clean Renewable Energy around the world, with an initial focus on North America. Our principal focus is to acquire evolving renewable technologies and to deliver reliable, clean energy that is harvested from local sustainable natural resources like Wind, Sun, Water and Earth.
GBEN is in the RIGHT INDUSTRY at the Time when our Country is witnessing a TECHNOLOGY EXPLOSION. We need to progress alternative means of Energy and GBEN is answering the call. Look at what a perfect industry this is for investors to be staking claims.
Fuel cell technology offers clean, efficient, reliable power generation to almost any device requiring electrical power.
It competes to replace a range of power supplies in many portable, stationary and transport applications, from battery chargers to home heating and power to cars.
Arguably, fuel cells represent the most versatile energy solution ever invented.
Over the last five years there has been a twenty-fold increase in shipments of fuel cells with year-on-year growth in both units and megawatts shipped.
In 2010, total shipments of fuel cells grew by 40% compared with the previous year, approaching a new high of 230,000 units. Portable fuel cells accounted for 95% of this total but there was substantial growth in other sectors.
Buyouts and corporate investments in both fuel cells and hydrogen will continue.
Remote sensing will be the 2012 breakout fuel cell market.
Renewables, storage, and fuel cells will converge in the off-grid power market.
Fuel cell and hydrogen industries will generate $785 million in revenue during 2012
We hope you enjoy this incredible Clean-Tech Trading Opportunity. Once every so often, a company comes along with a game-changing product in one of the Best Possible and Most In-Demand Markets. Usually these companies have HIGH Valuations as the market growth has been priced in.
GBEN is one such anomaly where the market has failed to give them their due credit. GBEN may shock the trading world and reward patient traders with several hundred % Gains if they can pull off only a fraction of what they are anticipating.
Start your research on GBEN right away as this could be an explosive opportunity.
Remember, trade smart, use stop losses and if you happen to see your self in profits, it could be
wise to take advantage of the situation.
Disclaimer: Stockchat LLC has received Twenty Thousand Dlrs for the awareness of GBEN by a non-controlling third party. Stockchat LLC has previously received Eleven Thousand Dlrs for the awareness of GBEN by a non-controlling third party which has expired.
The Movie Biz is BOOMING, and we have found you a company that is changing the way movies are made through eliminating process waste.
The key? Build a fully integrated movie and game production facility on a monstrous campus!!
How? Develop access to up to $300MIL in Industrial Development Bonds for the Project Capex!
This ~$2 Equity has been stair-stepping its way North since Mid-June with no end in sight. At that time, Volume started to Surge, and MDNT has been revealing Positive Press Release one after the other.
The Tone was set in March when this bombshell hit the wires - MDNT to Build America's Largest Movie Studio in Effingham, Georgia.
The good news kept flowing, and shareholder excitement has reached a climax:
Germany-based Atlas will provide up to $30 million as a sales advance to form part of the financing of the movies in the slate.
Medient's output is expected to reach 8 - 12 movies annually with budgets ranging from $2Million to $40Million. The formalization of this relationship is one step further in creating the circle of strategic alliances to realize the mega-studio complex in Effingham, GA
The IDA approved the issue of Industrial Development Bonds of up to Three Hundred Million Dollars ($300,000,000) to facilitate the capital expenditure of the project.
The parties are now finalizing the remaining closing conditions and the definitive agreements due to be completed prior to the July 17th.
Mr. Manu Kumaran, chairman and CEO of Medient, stated,
We are excited and happy that the operational phase of the project will soon commence and look forward to the opening of the facility. The IDA and Dennis and John have been extraordinary partners and we are privileged to have their support".
Medient Studios, Inc. (OTCQB: MDNT) is an entertainment content creation company with a strong presence in North America, Europe and India. Medient's management team has approximately 150 years of experience in the motion picture industry and is responsible for producing and/or financing over 250 movies. Medient is realigning the content creation process to enable efficiencies of scale and eliminate process waste by building a fully integrated movie and game production facility and campus on a 1550 acre property in Effingham County, Georgia. Once operational this production facility will be the largest of its kind in the United States.
The Company has produced a broad spectrum of films across various genres. These include such films as "Bombay Boys", a genre-defining Indie film that carried Indian cinema beyond the “song and dance” routine of Bollywood, and the award-winning Malayalam film "Aakshagopuram", which was the first Indian film to be entirely produced outside of that country. The film, which bought together talent from India and the UK, set a new benchmark in East - West collaboration. "Storage 24", a British horror film starring BAFTA award winner Noel Clarke was produced by Medient and released in 2012 by Universal Pictures.
Fore more corporate information visit MDNT's home site at http://medient.com/
Chance Raehn, Principal of Integrated Science & Engineering, Inc. the civil engineers for the project, stated:
"The focus is on the engineering tasks required to get the site 'construction ready' by November. The DRI and Traffic studies, Topography surveys for public areas and roads, Boundary surveys, Geotechnical investigations and Civil Design will all commence this
The project will feature:
a vertically integrated movie and electronic games production facility with a fully functional campus in the style adopted by the technology industry;
a pipeline that will facilitate the simultaneous production of movies in multiple languages and electronic games allowing simultaneous release of the same content to diverse audiences, thereby maximizing revenue; and
a combination of state approved tax credits, technology and equipment efficiencies, and insourcing to dramatically reduce the cost of film production while generating high quality content in the most successful movie genres.
Designed to be environmentally conscious and self-sustainable, the campus will include the application of solar and hydro technologies.
What are the Economic Benefits of the MDNT Studio Project? Are their Government Incentives involved?
Medient Studios Inc. will receive $3 million in state incentives for creating 1,000 jobs at a production and entertainment complex in Effingham County, according to CEO Manu Kumaran.
The deal with the Georgia Department of Community Affairs and Georgia Department of Economic Development calls for the company to receive a $3 million http://savannahnow.com/effingham-now/2013-05-17/medient-gets-3-million-state-tax-breaks#.UeWkBY3OvMt grant for site preparation and building improvements. It calls for $750,000 to be released after the first 250 jobs have been created and maintained for 12 months. Another $750,000 will be released after another 250 jobs are created and maintained for 12 months. And $1.5 million will be released after 500 more jobs are created and maintained for 12 months. The agreement says if not for the incentive, Medient might have located the project in New York or Pennsylvania.
With a ~38MIL OS, MDNT Stands to go on a price-run for the ages.
HOW Often do you see Small Cap Equities Involved in Projects of This Magnitude?
MDNT is Special! With several Catalysts Coming, NOW is a superb time to do your research well. Construction is nearing, hiring is happening, and bonds and incentives will be funneling in to position MDNT as an industry Innovator and Leader.
At ~$2, MDNT now has broken all 3 major SMA's and has support at ~$1.59 - the 20 SMA.
Accumulation remains Stellar and Trending higher while RSI maintains a positive position as well.
RSI is bullish at ~62, and volume continues to create liquidity and great trading opportunities.
As the Studioplex nears construction, the excitement is becoming palpable. We would not be surprised to see more major industry partners join in this cause.The business model is one of a kind as it streamlines many of the intricate ingredients that make up a major film.
MDNT is at the forefront of the industry, and they stand to increase their Sales Figures DRASTICALLY.
Major Bond Cash Flow, government incentives, construction and design players, and more are making this MDNT dream a reality, and we just had to share this trading opportunity with you. This is a once-in-a-lifetime project.
Start your research on MDNT right away as this could be an explosive opportunity.
Remember, trade smart, use stop losses and if you happen to see your self in profits,
it could be wise to take advantage of the situation.
007StockChat has purchased 80,000 shares of MDNT from a non-controlling third party. We reserve the right to liquidate and or add to our position before, during or after the release of this report. Liquidation and or adding to our position will be done without notice to any individual, party or reader. However, we will update our position as needed regarding our holdings in MDNT
AMMX has been trading in a channel book-ended by $.008 and $.018 since 2011. The Newest Mega-Deal may be the straw that breaks the camel's back! AMMX has been on a role in 2013 with some other Amazing Developments that will assist in boosting this company's valuation drastically:
The Recent AMMX 10-Q reported revenue of approximately $503,894 with gross profit of $302,755 compared to revenue of approximately $713,676 with gross profit of $232,541 for the comparable quarter ended March 31, 2012.
The AMMX Year End Financials reported a net income in 2012 for approximately $.276 million compared to net loss of $.132 million for the year ended December 31, 2011.
Gross Profits increased by $300k to $2.5MIL in 2012.
AMMX has engaged California-based Liquid Management Inc. to develop and execute a marketing/branding campaign. Liquid Management will introduce the company to broker-dealers and institutional investors through its public relations firm, the use of financial media and direct contact.
AmeraMex International sells, leases and rents heavy equipment to companies within four industries: construction (light and infrastructure), shipping logistics, mining and commercial farming.
AmeraMex International's largest product line is specialized container handling equipment that enables stevedoring companies to quickly and efficiently load and offload container and general freight ships dockside. Over the past 30 years, AmeraMex has grown from a used forklift dealer in Northern California to the owner and operator of a $5.0 million fleet of heavy equipment for sale, lease or rent to companies in the United States, as well as companies located in Africa, Canada, Indonesia, Germany, Singapore, Vietnam, China, Russia, Central America and Mexico. AmeraMex supplies heavy equipment to many different industries. The fastest growing market for AmeraMex is the shipping industry. The company maintains an extensive line of equipment for the loading and off-loading of shipping containers from ships coming in and going out of ports up and down the West Coast of the United States. For more information visit the AmeraMex website - www.AMMX.net Hamre Equipment Company is a Division of AMMX. For more information on this company please go HERE, and visit their Home Site - http://www.hamreequipment.com/
Take a Look at some of the Hamre Equipment Featured Listings on Machinery Trader HERE. Information on Hamre's Heavy Hauling such as Peterbilt Trucks and Cozad Heavy Haul Trailers visit HERE.
While there are several other Fronts that AMMX is developing business on both Geographically and in Different Industry Divisions, it would be foolish to not take a long, hard look at the Monster Release that was dropped today!
Under the terms of the contract, AmeraMex will replace heavy capacity trucks and trailers owned by the Department of Transportation in a North African country. The name of the country is not provided due to the competitive nature of the transaction.
Just exactly WHAT has to go down before AMMX can start acting on supplying Equipment and receiving funds?
The funding package for the replacement equipment has been approved by a New York City-based lending agency, subject to Bank Guarantees issued by the North African country's minister of finance. African Bank Guarantees can be problematic and require backing of a major corresponding European bank known by the lender.
If the Bank Guarantees are acceptable to the lender, AmeraMex will receive a complete list of required equipment from which to prepare a detailed proposal. The proposal will be presented to the Minister of Transportation for negotiations in preparation of a final contract. A signed contract must be provided and approved by the lender to complete the transaction. The total value of the contract, if all guarantees are accepted by the lending agency, will be approximately $500 million in gross sales over a five-year period.
If all goes well, AMMX Shareholders can start the party! This project and first shot with the Minister of Transportation could snowball into something beautiful and lucrative.
AmeraMex CEO Lee Hamre commented,
This is the culmination of many months of work and negotiations. A contract of this size will provide AmeraMex the funding to grow and expand the company, which will significantly increase shareholder value. We believe getting the first contract signed by the Minister of Transportation will open the door to many additional contracts within Northern Africa -- the first one is always the most difficult."
The AMMX Chart is locked in this channel, but it may be Go-Time after this Green Light Release today! Take a Look at the Daily Chart:
AMMX has broken and held the 50SMA at $.011 and now faces resistance with the 20SMA at $.013.
Accumulation continues to be strong showcasing Buys even in the midst of lower volumes.
The 200 SMA is a likely initial trading Target at $.014 - a Break could ignite a run to the Channel Ceiling at $.018 and well Beyond!
RSI is nearly Bullish at ~50, and Traders are more pumped than ever with recent news!
Recent release was about as good as it gets for this diversified International Equipment Company. AMMX has a Bright Future ahead of itself if they can capitalize on a few of their projects. Management has shown to practice financial accountability as they have achieved better scores QoQ and YoY now.
Start your research on AMMX right away as this could be an explosive opportunity.
Remember, trade smart, use stop losses and if you happen to see your self in profits,
it could be wise to take advantage of the situation.
Spy Hard, Profit Easy
Disclaimer: Stockchat LLC has received Two thousand Five Hundre Dlrs for the awareness of AMMX by a non-controlling third part.
With the precious metals panic selling coming to an end and the bottom in sight, the time to get in on and profit on companies like CGRABefore the Panic BUYING comes back in, is Now!
CGRA chart shows that three times now over 100% gains have been possible on multi week trades.
CGRA has been trading in a side ways chanel for almost 5 weeks, meaning a break out could occurr at any moment. IMO
Hold on though.... CGRA is not just a pretty chart, there is more then meets the eye.....
CGRA looks especially shiny with partner Jason Otteson from Noble Mining on board which was recently featured on the hit show "Gold Rush" ( Click Here )
CGRA partner Jason Otteson has an incredibly profitable track record and just about anything he`s involved in to turns to gold, CGRA could do well moving forward!
If your not familiar, CGRA partner Jason Otteson has Extensive Experience in Bullion Distribution and Many years in Bullion investing. His Bullion investments have brought success to many clients and With over 22 years of entrepreneurial experience, Jason has a proven track record of growing small startups into profitable, multi-million dollar entities. Prior to Noble Mining, Jason was a leader of a large precious metals investment firm. Previously, Jason was the CEO of Sportan United Industries, Inc., where he led the firm through an IPO, and a successful acquisition. To Jason, the precious metals industry is more than another business; he sees this as a stable harbor for himself, family, friends and clients in this current economic storm.
"The initial contract is for the removal of 49,900 cubic yards of material with a potential gross value exceeding $640,000. The Company is working with CGrowth and the Bureau of Land Management ("BLM") to increase the quantity of material to be extracted and sold to 2,000,000 cubic yards over a 5-year period."
"The contract calls for total payments of $350,000 in working capital to the project within the next 30 days. "
If a light bulb did not just go off, then you need to read that PR again.
Only 20 day left until the funds are due which is a nice revenue stream for an 8 cent company, and investors are paying attention as the price has gradually begun to move upward.
Lets not forget JPX Global is a publicly traded company currently trading at over a dollar.
CGRA - BUSINESS MODEL
CGRA Serves as a holding company ??for businesses and assets focused on all aspects of mining. The processing of metal ore mining is a multi-billion dollar market opportunity which is capitalized through processing, sales, contracting and licensing of assets. CGrowth’s services and solutions are designed to assist land owners with monetizing undervalued assets by bringing commodities such as gold and silver to market.
CGRA will focus on acquiring or “claiming” land assets, while also providing partners and affiliates with management services, capital, contract management and logistical services necessary for the successful execution of mining operations. The CGrowth mission is to create shareholder value by consolidating assets within a fragmented mining industry through synergistic acquisitions, mergers, joint ventures and strategic hires. The Company will also focus on purchasing secondary claims and assets in various locations then providing ore processing support through its processing plant partners.
Established in 1986, CGrowth Capital, Inc., a Delaware corporation, began its restructuring and business shift in 2009 with the goal of identifying a fragmented industry with large upside returns. The company concluded in early 2012 that the mining industry presented extraordinary opportunities for its shareholders and investors after reviewing several acquisition opportunities and proposals.
Among the positives the mining focus brings:
The industry deals with commodities that are high in demand worldwide
Valuation of the assets is fixed as a commodity.
Transformation of the assets, from raw earth to precious minerals, brings tremendous value change from its original form.
The industry in the United States has remained extremely fragmented.
As you can see, CGRA has potential, and a few lucky individuals have uncovered this under the radar play and have begun to take position.
Now its time for you to take part, and enjoy the fruits of success.
Start your research on CGRA right away as this could be an explosive opportunity.
Remember, trade smart, use stop losses and if you happen to see your self in profits, it could be
wise to take advantage of the situation.
Spy Hard, Profit Easy
Stockchat LLC has received Three Thousand Five Hundred Dlrs for the awareness of CGRA by a non-controlling third party. Stockchat LLC has previously received Fifteen Thousand Dlrs for the awareness of CGRA by a non-controlling third party for which the contract has expired.
The Medical Marijuana Industry continues to expand in stellar fashion Domestically.
FITX entered the industry before it is too late, before market share has received a death grip. FITX is making ALL OF THE RIGHT MOVES that Shareholders want to see from a growth industry trying to grow sales and their brand name in every means possible.
FITX is aggressively looking to acquire licenses and brands in the industrial hemp and medical marijuana industry in order to capitalize on this growing market sector.
Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. Visit www.CenergyNutrition.com and https://www.facebook.com/CenergyNutrition for up-to-date information on FITX.
FITX is proud to introduce these new innovative proteins which will complement existing product lines, as Creative Edge Nutrition, Inc. generated over $2.5 million in revenue last year.
That is right, this $.0044 stock already does $2.5MIL in sales BEFORE they add their aggressive and complimentary Marijuana-based Products. These are some of the Products that will be BOOSTING SALES IN A NEW AND LUCRATIVE INDUSTRY -
Coffee is Another Monster Market that FITX has wisely entered in the special way they know how. The CEO had this to say,
We are planning to aggressively market our products in the billion dollar coffee and tea business sector. We envision our products to be available in many new outlets where dietary supplements are not currently sold. These products were a vision created by our cutting edge product development team."
These cheap prices offer HUGE % Swing Opportunities that savvy traders like us love to abuse! Dilution was not the main verdict, but INSTEAD on April 1st FITX engineered a FORWARD SPLIT after pushing for a similar Stock Dividend. Management has gained the trust of FITX shareholders and rewarded them since then with some Growth Strategies sure to build value:
FITX is using Social Mediums to build Brand Awareness and release important News.
Sales Growth via Acquisitions? FITX Secured this by Acquiring 3 Canadian Nutrition Superstores (http://canadiannutrition.ca/) targeting the Toronto market. FTIX CEO had this to say about the expected sales growth: "This will allow us additional outlets to sell our Cenergy and SDN brands and capitalize on the multiple profit streams which result from vertical integration. The opportunity that this deal has provided to all parties is noteworthy and we look forward to the future and fits well with our plan. We are actively seeking more acquisitions to fill our model." Yes, MORE ACQUISITIONS ARE COMING!
ProSource will carry the entire Cenergy Nutrition line of products.
007 often stresses that a plan, product, technology, and vision mean NOTHING without the right proven and ambitious Management Team pulling the strings. FITX has made several moves recently to augment and expand their personnel.
Sam has one of the largest compounding pharmacies in the state of Michigan and is in the process of registration to be a federally licensed Drug Manufacturing and Distribution facility.
Among a laundry list of medical expertise, Sam brings over a decade of experience in Drug research & development and drug and neutraceutical delivery mechanisms.
If you read PR's closely you will see that FITX has some Imminent Mega-releases on the way. Bill Chaaban stated
I am excited to have Sam join our team. It provides the much needed avenue to do things within the current regulatory framework. We have many exciting announcements to come. We have been very busy the past few months laying the groundwork to implement our vertical integration model."
Get this!!! Mr. Armenta was instrumental in placing MusclePharm into the largest US distributors and in over 35 International countries. He helped the company grow from $96,000 in sales in 2008, to over $17M in sales in 2011.
"The Business of Medical Marijuana" the medical cannabis industry alone was worth about 1.7 billion in 2011, according to a report by the financial news firm See Change Strategy. That figure could reach nearly $9 billion nationwide in five years, as more states are likely to legalize marijuana for medicinal purposes. FITX is seeking to capture a % Share of this Booming Market worth Several Billions of Dollars.
At $.0044, with over $2.5MIL in Sales before adding the Marijuana Divisions and Product lineup, FITX offers a Substantial Upside. If FITX nears $10MIL-$20MIL in Annualized Sales, what sort of Market Caps can you envision? $.0044 is starting to look even cheaper!
Look at the DAILY CHART. 22% and 52% seem to be the most logical, Potential gains as FITX pushes upwards.
FITX is flirting with the 20sma at $.0045 and is tantalizingly close to a break and hold which may catalyze a price and volume explosion.
The Last 20SMA Break in Early June sent the stock running to the 50SMA.
RSI is nearing a Bullish 50 Break, and MACD just had a + Break and is trending higher.
Resistance at the 50SMA ($.0054) and 200 SMA ($.0067) pose as initial 22%-52% possible returns.
As Sales Increases and Expected Releases create an even greater stir, FITX may return to a higher channel from early April at $.015. FITX can run on Fundamentals or a Technical Breakout and return there for a potential 240% gain!!! Yes there is some monster money to be made on FITX, and they have SET THE STAGE perfectly.
They are growing Sales through ONLINE VENUES as well as Physical Locations that they purchased! They have accessed mega-markets such as medical marijuana, supplements, tea, coffee, and more with Unique Product lines. They have even recruited top-level industry talent to procure more growth and continue this ambitious business strategy.
Start your research on FITX right away as this could be an explosive opportunity.
Remember, trade smart, use stop losses and if you happen to see your self in profits, it could be
wise to take advantage of the situation.
Spy Hard, Profit Easy
Stockchat LLC has received three thousand five hundred dlrs for the awareness of FITX by a non-controlling third party.